"rct_name"	"trial_database_urls"	"intervention_type"	"trial_phase"	"n_centres"	"n_centres_cat"	"n_randomised_participants"	"n_randomised_participants_cat"	"only_covid_patients"	"recruitment_period"	"recruitment_start"	"recruitment_end"	"recruitment_duration_years"	"journal_principal_report"	"publication_year_principal_report"	"doi_principal_report"	"any_predictive_enrichment"	"trial_stopped_early"	"trial_stopped_predefined_rule"	"trial_stopped_reason"	"trial_stopped_reason_grouped"	"title_principal_report"	"email_response"
"AKIKI 2016"	"None"	"Management"	"Not drug trial"	31	"(20,40]"	84	"(0,100]"	"No"	"2/2013-12/2015"	"2013-02-01"	"2015-12-01"	2.83013698630137	"NEJM"	2016	"10.1056/NEJMoa1603017"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit"	"No reply"
"deGrooth 2018"	"None"	"Drug"	"4"	1	"(0,1]"	20	"(0,100]"	"No"	"3/2015-11/2016"	"2015-03-01"	"2016-11-01"	1.6712328767123288	"Chest"	2018	"10.1016/j.chest.2018.02.025"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Vitamin C Pharmacokinetics in Critically Ill Patients: A Randomized Trial of Four IV Regimens"	"Not used"
"HYPERION 2019"	"None"	"Management"	"Not drug trial"	25	"(20,40]"	584	"(500,1000]"	"No"	"1/2014-1/2018"	"2014-01-01"	"2018-01-01"	4	"NEJM"	2019	"10.1056/NEJMoa1906661"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm"	"Not used"
"INTEREST 2020"	"None"	"Drug"	"3"	47	"(40,100]"	301	"(250,500]"	"No"	"12/2015-12/2017"	"2015-12-01"	"2017-12-01"	2	"JAMA"	2020	"10.1001/jama.2019.22525"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Intravenous Interferon \u0152\u2264-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial"	"No reply"
"Merz 2019"	"None"	"Device"	"Not drug trial"	1	"(0,1]"	550	"(500,1000]"	"No"	"3/2014-10/2017"	"2014-03-01"	"2017-10-01"	3.5863013698630137	"Intensive Care Med"	2019	"10.1007/s00134-019-05670-6"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Continual hemodynamic monitoring with a single-use transesophageal echocardiography probe in critically ill patients with shock: a randomized controlled clinical trial"	"Not used"
"MOTION 2020"	"None"	"Drug"	"4"	4	"(1,5]"	84	"(0,100]"	"No"	"3/2015-12/2018"	"2015-03-01"	"2018-12-01"	3.7534246575342465	"Intensive Care Med"	2020	"10.1007/s00134-019-05913-6"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial"	"No reply"
"POPPI 2019"	"None"	"Management"	"Not drug trial"	24	"(20,40]"	1458	"(1000,2000]"	"No"	"9/2015-1/2017"	"2015-09-01"	"2017-01-01"	1.3342465753424657	"JAMA"	2019	"10.1001/jama.2019.0073"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of a Nurse-Led Preventive Psychological Intervention on Symptoms of Posttraumatic Stress Disorder Among Critically Ill Patients A Randomized Clinical Trial"	"No reply"
"PROHIBIT 2018"	"None"	"Management"	"Not drug trial"	14	"(10,20]"	25348	"(5000,26982]"	"No"	"1/2011-6/2013"	"2011-01-01"	"2013-06-01"	2.4136986301369863	"Intensive Care Med"	2018	"10.1007/s00134-017-5007-6"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Prevention of hospital infections by intervention and training (PROHIBIT): results of a pan-European cluster-randomized multicentre study to reduce central venous catheter-related bloodstream infections"	"No reply"
"STARRT-AKI 2020"	"None"	"Management"	"Not drug trial"	168	"(100,393]"	3019	"(2000,5000]"	"No"	"10/2015-9/2019"	"2015-10-01"	"2019-09-01"	3.9178082191780823	"NEJM"	2020	"10.1056/NEJMoa2000741"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury"	"Not used"
"VANCS II 2019"	"None"	"Drug"	"3"	1	"(0,1]"	250	"(100,250]"	"No"	"7/2014-7/2016"	"2014-07-01"	"2016-07-01"	2	"Crit Care Med"	2019	"10.1097/CCM.0000000000004023"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial"	"No reply"
"ACCOST-HH 2022"	"https://clinicaltrials.gov/ct2/show/NCT03989531"	"Drug"	"2+3"	4	"(1,5]"	150	"(100,250]"	"No"	"4/2019-1/2021"	"2019-04-01"	"2021-01-01"	1.7534246575342465	"Lancet Respir Med"	2022	"10.1016/S2213-2600(21)00439-2"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial"	"No reply"
"Adlbrecht 2020"	"https://clinicaltrials.gov/ct2/show/NCT01563263"	"Drug"	"2+3"	52	"(40,100]"	799	"(500,1000]"	"No"	"3/2012-8/2015"	"2012-03-01"	"2015-08-01"	3.418032786885246	"Crit Care"	2020	"10.1186/s13054-020-2792-z"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients—a randomized clinical trial"	"No reply"
"ADRENAL 2018"	"https://clinicaltrials.gov/ct2/show/NCT01448109"	"Drug"	"4"	69	"(40,100]"	3800	"(2000,5000]"	"No"	"3/2013-4/2017"	"2013-03-01"	"2017-04-01"	4.0849315068493155	"NEJM"	2018	"10.1056/NEJMoa1705835"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Adjunctive Glucocorticoid Therapy in Patients with Septic Shock"	"No reply"
"AGATE 2021"	"https://clinicaltrials.gov/ct2/show/NCT02534974"	"Device"	"Not drug trial"	13	"(10,20]"	437	"(250,500]"	"No"	"7/2015-2/2018"	"2015-07-01"	"2018-02-01"	2.589041095890411	"Chest"	2021	"10.1016/j.chest.2021.03.007"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Continuous Pneumatic Regulation of Tracheal Cuff Pressure to Decrease Ventilator-associated Pneumonia in Trauma Patients Who Were Mechanically Ventilated: The AGATE Multicenter Randomized Controlled Study"	"Not used"
"AKIKI 2 2021"	"https://clinicaltrials.gov/ct2/show/NCT03396757"	"Management"	"Not drug trial"	39	"(20,40]"	278	"(250,500]"	"No"	"5/2018-10/2019"	"2018-05-01"	"2019-10-01"	1.418032786885246	"Lancet"	2021	"10.1016/S0140-6736(21)00350-0"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial"	"No reply"
"ANALGESIC 2021"	"None"	"Drug"	"2"	2	"(1,5]"	737	"(500,1000]"	"No"	"7/2019-8/2020"	"2019-07-01"	"2020-08-01"	1.084931506849315	"Am J Respir Crit Care Med"	2021	"10.1164/rccm.202106-1515OC"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"A Phase II Cluster-Crossover Randomized Trial of Fentanyl versus Morphine for Analgosedation in Mechanically Ventilated Patients"	"Not used"
"ANTHARTIC 2019"	"https://clinicaltrials.gov/ct2/show/NCT02186951"	"Drug"	"3"	16	"(10,20]"	198	"(100,250]"	"No"	"8/2014-9/2017"	"2014-08-01"	"2017-09-01"	3.084931506849315	"NEJM"	2019	"10.1056/NEJMoa1812379"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest"	"Not used"
"APROCCHSS 2018"	"https://clinicaltrials.gov/ct2/show/NCT00625209"	"Drug"	"3"	34	"(20,40]"	1241	"(1000,2000]"	"No"	"9/2008-6/2015"	"2008-09-01"	"2015-06-01"	6.747945205479452	"NEJM"	2018	"10.1056/NEJMoa1705716"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Hydrocortisone plus Fludrocortisone for Adults with Septic Shock"	"No reply"
"ASPECT-NP 2019"	"https://clinicaltrials.gov/ct2/show/NCT02070757"	"Drug"	"3"	263	"(100,393]"	726	"(500,1000]"	"No"	"1/2015-4/2018"	"2015-01-01"	"2018-04-01"	3.2465753424657535	"Lancet Infect Dis"	2019	"10.1016/S1473-3099(19)30403-7"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial"	"No reply"
"Atan 2018"	"https://clinicaltrials.gov/ct2/show/NCT00912184"	"Device"	"Not drug trial"	1	"(0,1]"	76	"(0,100]"	"No"	"5/2009-12/2011"	"2009-05-01"	"2011-12-01"	2.5846994535519126	"Crit Care Med"	2018	"10.1097/CCM.0000000000003350"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"A Double-Blind Randomized Controlled Trial of High Cutoff Versus Standard Hemofiltration in Critically Ill Patients With Acute Kidney Injury"	"No reply"
"ATESS 2020"	"None"	"Drug"	"2"	4	"(1,5]"	116	"(100,250]"	"No"	"12/2018-1/2020"	"2018-12-01"	"2020-01-01"	1.0846994535519126	"Intensive Care Med"	2020	"10.1007/s00134-020-06191-3"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Combination therapy of vitamin C and thiamine for septic shock: a multi-centre, double-blinded randomized, controlled study"	"No reply"
"BACLOREA 2021"	"https://clinicaltrials.gov/ct2/show/NCT02723383"	"Drug"	"3"	18	"(10,20]"	314	"(250,500]"	"No"	"6/2016-2/2018"	"2016-06-01"	"2018-02-01"	1.6712328767123288	"JAMA"	2021	"10.1001/jama.2021.0658"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of High-Dose Baclofen on Agitation-Related Events Among Patients With Unhealthy Alcohol Use Receiving Mechanical Ventilation A Randomized Clinical Trial"	"No reply"
"BaSICs 2021"	"https://clinicaltrials.gov/ct2/show/NCT02875873"	"Drug"	"3"	75	"(40,100]"	11052	"(5000,26982]"	"No"	"5/2017-3/2020"	"2017-05-01"	"2020-03-01"	2.8333333333333335	"JAMA"	2021	"10.1001/jama.2021.11444"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Slower vs Faster Intravenous Fluid Bolus Rates on Mortality in Critically Ill Patients The BaSICS Randomized Clinical Trial"	"Not used"
"Beitler 2019"	"https://clinicaltrials.gov/ct2/show/NCT01681225"	"Management"	"Not drug trial"	14	"(10,20]"	202	"(100,250]"	"No"	"10/2012-9/2017"	"2012-10-01"	"2017-09-01"	4.917808219178082	"JAMA"	2019	"10.1001/jama.2019.0555"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure–Guided Strategy vs an Empirical High PEEP-FIO2 Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial"	"No reply"
"BICAR-ICU 2018"	"https://clinicaltrials.gov/ct2/show/NCT02476253"	"Drug"	"3"	26	"(20,40]"	400	"(250,500]"	"No"	"5/2015-5/2017"	"2015-05-01"	"2017-05-01"	2	"Lancet"	2018	"10.1016/S0140-6736(18)31080-8"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial"	"No reply"
"Borges 2020"	"https://clinicaltrials.gov/ct2/show/NCT02987790"	"Management"	"Not drug trial"	2	"(1,5]"	135	"(100,250]"	"No"	"1/2017-5/2018"	"2017-01-01"	"2018-05-01"	1.3287671232876712	"Crit Care"	2020	"10.1186/s13054-020-02946-y"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Duration of antibiotic therapy in critically ill patients: a randomized controlled trial of a clinical and C-reactive protein-based protocol versus an evidence-based best practice strategy without biomarkers"	"No reply"
"BOUGIE 2021"	"https://clinicaltrials.gov/ct2/show/NCT03928925"	"Device"	"Not drug trial"	15	"(10,20]"	1106	"(1000,2000]"	"No"	"4/2019-2/2021"	"2019-04-01"	"2021-02-01"	1.8383561643835615	"JAMA"	2021	"10.1001/jama.2021.22002"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Use of a Bougie vs Endotracheal Tube With Stylet on Successful Intubation on the First Attempt Among Critically Ill Patients Undergoing Tracheal Intubation: A Randomized Clinical Trial"	"No reply"
"BPCTrea 2018"	"None"	"Management"	"Not drug trial"	11	"(10,20]"	302	"(250,500]"	"No"	"10/2010-3/2016"	"2010-10-01"	"2016-03-01"	5.415300546448087	"Intensive Care Med"	2018	"10.1007/s00134-018-5141-9"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study"	"No reply"
"Buchtele 2022"	"https://clinicaltrials.gov/ct2/show/NCT02895373"	"Drug"	"2"	2	"(1,5]"	50	"(0,100]"	"No"	"9/2016-4/2021"	"2016-09-01"	"2021-04-01"	4.580821917808219	"Am J Respir Crit Care Med"	2022	"10.1164/rccm.202110-2359OC"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Add-on Prostaglandin E1 in Venovenous Extracorporeal Membrane Oxygenation: A Randomized, Double-blind, Placebo-controlled Pilot Trial"	"Not used"
"CAPITAL CHILL 2021"	"https://clinicaltrials.gov/ct2/show/NCT02011568"	"Management"	"Not drug trial"	1	"(0,1]"	389	"(250,500]"	"No"	"8/2013-3/2020"	"2013-08-01"	"2020-03-01"	6.581967213114754	"JAMA"	2021	"10.1001/jama.2021.15703"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes in Comatose Survivors of Out-of-Hospital Cardiac Arrest The CAPITAL CHILL Randomized Clinical Trial"	"No reply"
"Carteron 2021"	"None"	"Drug"	"3"	1	"(0,1]"	206	"(100,250]"	"No"	"6/2012-2/2019"	"2012-06-01"	"2019-02-01"	6.671232876712329	"Crit Care"	2021	"10.1186/s13054-020-03456-7"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Semi-elemental versus polymeric formula for enteral nutrition in brain-injured critically ill patients: a randomized trial"	"Not used"
"CHORAL 2021"	"https://clinicaltrials.gov/ct2/show/NCT03382730"	"Management"	"Not drug trial"	6	"(5,10]"	3260	"(2000,5000]"	"No"	"12/2017-1/2019"	"2017-12-01"	"2019-01-01"	1.084931506849315	"Intensive Care Med"	2021	"10.1007/s00134-021-06475-2"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of oral chlorhexidine de-adoption and implementation of an oral care bundle on mortality for mechanically ventilated patients in the intensive care unit (CHORAL): a multi-center stepped wedge cluster-randomized controlled trial"	"Not used"
"CITRIS-ALI 2019"	"https://clinicaltrials.gov/ct2/show/NCT02106975"	"Drug"	"2"	7	"(5,10]"	170	"(100,250]"	"No"	"9/2014-11/2017"	"2014-09-01"	"2017-11-01"	3.1671232876712327	"JAMA"	2019	"10.1001/jama.2019.11825"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure The CITRIS-ALI Randomized Clinical Trial"	"No reply"
"CoDEX 2020"	"https://clinicaltrials.gov/ct2/show/NCT04327401"	"Drug"	"3"	41	"(40,100]"	299	"(250,500]"	"Yes"	"4/2020-6/2020"	"2020-04-01"	"2020-06-01"	0.16712328767123288	"JAMA"	2020	"10.1001/jama.2020.17021"	"Yes"	"Yes"	"No"	"Loss of equipose due to publication of dexamethason study from RECOVERY"	"Loss of equipoise"	"Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial"	"No reply"
"COMACARE 2018"	"None"	"Management"	"Not drug trial"	6	"(5,10]"	123	"(100,250]"	"No"	"3/2016-11/2017"	"2016-03-01"	"2017-11-01"	1.6712328767123288	"Intensive Care Med"	2018	"10.1007/s00134-018-5446-8"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Targeting low-normal or high-normal mean arterial pressure after cardiac arrest and resuscitation: a randomised pilot trial"	"Not used"
"COMBAT-COVID 2022"	"https://clinicaltrials.gov/ct2/show/NCT04420741, https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001296-33/results"	"Drug"	"2"	5	"(1,5]"	80	"(0,100]"	"Yes"	"6/2020-1/2021"	"2020-06-01"	"2021-01-01"	0.5863013698630137	"Am J Respir Crit Care Med"	2022	"10.1164/rccm.202108-1855OC"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Prostacyclin in Intubated Patients with COVID-19 and Severe Endotheliopathy: A Multicenter, Randomized Clinical Trial"	"Not used"
"COMPACT-2 2021"	"https://clinicaltrials.gov/ct2/show/NCT01639664"	"Management"	"Not drug trial"	12	"(10,20]"	115	"(100,250]"	"No"	"5/2015-10/2017"	"2015-05-01"	"2017-10-01"	2.419178082191781	"Intensive Care Med"	2021	"10.1007/s00134-021-06501-3"	"No"	"Yes"	"No"	"Possible harm"	"Safety"	"High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial"	"No reply"
"DESIRE 2017"	"https://clinicaltrials.gov/ct2/show/NCT01760967"	"Drug"	"4"	8	"(5,10]"	201	"(100,250]"	"No"	"2/2013-1/2016"	"2013-02-01"	"2016-01-01"	2.915068493150685	"JAMA"	2017	"10.1001/jama.2017.2088"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Dexmedetomidine on Mortality and Ventilator-Free Days in Patients Requiring Mechanical Ventilation With Sepsis A Randomized Clinical Trial"	"No reply"
"Doig 2015"	"ANZCTR/ACTRN12609001015235"	"Drug"	"2"	16	"(10,20]"	474	"(250,500]"	"No"	"12/2010-2/2013"	"2010-12-01"	"2013-02-01"	2.16986301369863	"Intensive Care Med"	2015	"10.1007/s00134-015-3827-9"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial"	"No reply"
"EOLIA 2018"	"https://clinicaltrials.gov/ct2/show/NCT01470703"	"Device"	"Not drug trial"	64	"(40,100]"	249	"(100,250]"	"No"	"12/2011-7/2017"	"2011-12-01"	"2017-07-01"	5.580821917808219	"NEJM"	2018	"10.1056/NEJMoa1800385"	NA	"Yes"	"Yes"	"Futility"	"Futility"	"Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome"	"No reply"
"FIBRES 2019"	"https://clinicaltrials.gov/ct2/show/NCT03037424"	"Drug"	"3"	11	"(10,20]"	827	"(500,1000]"	"No"	"2/2017-11/2018"	"2017-02-01"	"2018-11-01"	1.7479452054794522	"JAMA"	2019	"10.1001/jama.2019.17312"	"No"	"Yes"	"Yes"	"Noninferiority"	"Non-inferiority"	"Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery The FIBRES Randomized Clinical Trial"	"Not used"
"Francois 2020"	"None"	"Drug"	"2a"	11	"(10,20]"	50	"(0,100]"	"No"	"7/2017-6/2018"	"2017-07-01"	"2018-06-01"	0.9178082191780822	"Intensive Care Med"	2020	"10.1007/s00134-020-06109-z"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial"	"Not used"
"FROST-I 2018"	"https://clinicaltrials.gov/ct2/show/NCT02035839"	"Management"	"Not drug trial"	16	"(10,20]"	150	"(100,250]"	"No"	"5/2014-4/2016"	"2014-05-01"	"2016-04-01"	1.918032786885246	"Intensive Care Med"	2018	"10.1007/s00134-018-5256-z"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"A multicentre randomized pilot trial on the effectiveness of different levels of cooling in comatose survivors of out-of-hospital cardiac arrest: the FROST-I trial"	"No reply"
"Gandolfi 2020"	"None"	"Drug"	"4"	2	"(1,5]"	206	"(100,250]"	"No"	"3/2016-6/2019"	"2016-03-01"	"2019-06-01"	3.251366120218579	"Crit Care Med"	2020	"10.1097/CCM.0000000000004690"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"The Effects of Melatonin Supplementation on Sleep Quality and Assessment of the Serum Melatonin in ICU Patients: A Randomized Controlled Trial"	"Not used"
"Gehlbach 2018"	"None"	"Management"	"Not drug trial"	2	"(1,5]"	24	"(0,100]"	"No"	"1/2011-12/2016"	"2011-01-01"	"2016-12-01"	5.915300546448087	"Am J Respir Crit Care Med"	2018	"10.1164/rccm.201801-0170LE"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"The Effects of Timed Light Exposure in Critically Ill Patients: A Randomized Controlled Pilot Clinical Trial"	"Not used"
"Grifols Antithrombin Research Award study 2020"	"None"	"Drug"	"2+3"	2	"(1,5]"	49	"(0,100]"	"No"	"8/2017-3/2019"	"2017-08-01"	"2019-03-01"	1.580821917808219	"Crit Care Med"	2020	"10.1097/CCM.0000000000004590"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"A Randomized Controlled Trial of Antithrombin Supplementation During Extracorporeal Membrane Oxygenation"	"Not used"
"Guinot 2020"	"https://clinicaltrials.gov/ct2/show/NCT03951519"	"Management"	"Not drug trial"	1	"(0,1]"	50	"(0,100]"	"No"	"5/2019-2/2020"	"2019-05-01"	"2020-02-01"	0.7540983606557377	"Intensive Care Med"	2020	"10.1007/s00134-020-06215-y"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Oral water ingestion in the treatment of shock patients: a prospective randomized study"	"Not used"
"Hadfield 2020"	"https://clinicaltrials.gov/ct2/show/NCT01826890"	"Device"	"Not drug trial"	4	"(1,5]"	78	"(0,100]"	"No"	"5/2013-3/2018"	"2013-05-01"	"2018-03-01"	4.832876712328767	"Crit Care"	2020	"10.1186/s13054-020-02923-5"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Neurally adjusted ventilatory assist versus pressure support ventilation: a randomized controlled feasibility trial performed in patients at risk of prolonged mechanical ventilation"	"Not used"
"HARP-2 2014"	"None"	"Drug"	"2"	40	"(20,40]"	540	"(500,1000]"	"No"	"12/2010-3/2014"	"2010-12-01"	"2014-03-01"	3.2465753424657535	"NEJM"	2014	"10.1056/NEJMoa1403285"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Simvastatin in the Acute Respiratory Distress Syndrome"	"No reply"
"He 2021"	"https://clinicaltrials.gov/ct2/show/NCT02361398"	"Device"	"Not drug trial"	1	"(0,1]"	126	"(100,250]"	"No"	"11/2018-9/2020"	"2018-11-01"	"2020-09-01"	1.8333333333333335	"Crit Care"	2021	"10.1186/s13054-021-03645-y"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Early individualized positive end-expiratory pressure guided by electrical impedance tomography in acute respiratory distress syndrome: a randomized controlled clinical trial"	"No reply"
"HERACLES 2020"	"None"	"Drug"	"2"	1	"(0,1]"	165	"(100,250]"	"No"	"2/2018-8/2019"	"2018-02-01"	"2019-08-01"	1.4958904109589042	"Intensive Care Med"	2020	"10.1007/s00134-020-06132-0"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Hypertonic saline for fluid resuscitation in ICU patients post-cardiac surgery (HERACLES): a double-blind randomized controlled clinical trial"	"Not used"
"HIGH 2018"	"https://clinicaltrials.gov/ct2/show/NCT02739451"	"Device"	"Not drug trial"	32	"(20,40]"	778	"(500,1000]"	"No"	"5/2016-12/2017"	"2016-05-01"	"2017-12-01"	1.5863013698630137	"JAMA"	2018	"10.1001/jama.2018.14282"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure The HIGH Randomized Clinical Trial"	"No reply"
"Ho 2019"	"ANZCTR/ACTRN12614000963628"	"Device"	"Not drug trial"	4	"(1,5]"	240	"(100,250]"	"No"	"6/2015-12/2017"	"2015-06-01"	"2017-12-01"	2.5013698630136987	"NEJM"	2019	"10.1056/NEJMoa1806515"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"A Multicenter Trial of Vena Cava Filters in Severely Injured Patients"	"Not used"
"Hotchkiss 2019a"	"https://clinicaltrials.gov/ct2/show/NCT02960854"	"Drug"	"1b"	10	"(5,10]"	31	"(0,100]"	"No"	"1/2017-1/2018"	"2017-01-01"	"2018-01-01"	1	"Intensive Care Med"	2019	"10.1007/s00134-019-05704-z"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab"	"No reply"
"HOT-ICU 2021"	"https://clinicaltrials.gov/ct2/show/NCT03174002"	"Drug"	"4"	35	"(20,40]"	2928	"(2000,5000]"	"No"	"6/2017-8/2020"	"2017-06-01"	"2020-08-01"	3.1671232876712327	"NEJM"	2021	"10.1056/NEJMoa2032510"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure"	"Not used"
"Hotchkiss 2019b"	"https://clinicaltrials.gov/ct2/show/NCT02576457"	"Drug"	"1b"	7	"(5,10]"	25	"(0,100]"	"No"	"12/2015-12/2016"	"2015-12-01"	"2016-12-01"	1	"Crit Care Med"	2019	"10.1097/CCM.0000000000003685"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)"	"No reply"
"Hu 2018"	"None"	"Drug"	"3"	8	"(5,10]"	332	"(250,500]"	"No"	"10/2016-7/2018"	"2016-10-01"	"2018-07-01"	1.7479452054794522	"Intensive Care Med"	2018	"10.1007/s00134-018-5466-4"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Erythromycin versus metoclopramide for post-pyloric spiral nasoenteric tube placement: a randomized non-inferiority trial"	"No reply"
"HYPERS2S 2017"	"None"	"Drug"	"4"	22	"(20,40]"	442	"(250,500]"	"No"	"11/2012-6/2014"	"2012-11-01"	"2014-06-01"	1.580821917808219	"Lancet Respir Med"	2017	"10.1016/S2213-2600(17)30046-2"	"No"	"Yes"	"No"	"Excess risk and the absence of any benefit of both experimental interventions"	"Safety"	"Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial"	"Not used"
"IDEAL-ICU 2018"	"https://clinicaltrials.gov/ct2/show/NCT01682590"	"Management"	"Not drug trial"	29	"(20,40]"	488	"(250,500]"	"No"	"7/2012-10/2016"	"2012-07-01"	"2016-10-01"	4.252054794520548	"NEJM"	2018	"10.1056/NEJMoa1803213"	"No"	"Yes"	"Yes"	"Futility"	"Futility"	"Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis"	"No reply"
"INSPIRATION 2021"	"https://clinicaltrials.gov/ct2/show/NCT04486508"	"Drug"	"3"	10	"(5,10]"	600	"(500,1000]"	"Yes"	"7/2020-11/2020"	"2020-07-01"	"2020-11-01"	0.336986301369863	"JAMA"	2021	"10.1001/jama.2021.4152"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial"	"No reply"
"IRIHS 2021"	"https://clinicaltrials.gov/ct2/show/NCT02345681"	"Drug"	"3"	4	"(1,5]"	171	"(100,250]"	"No"	"5/2015-2/2019"	"2015-05-01"	"2019-02-01"	3.756164383561644	"Crit Care"	2021	"10.1186/s13054-021-03509-5"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Diuretics decrease fluid balance in patients on invasive mechanical ventilation: the randomized-controlled single blind, IRIHS study."	"No reply"
"ISOCRATE 2021"	"https://clinicaltrials.gov/ct2/show/NCT02555254"	"Management"	"Not drug trial"	1	"(0,1]"	50	"(0,100]"	"No"	"2/2016-5/2020"	"2016-02-01"	"2020-05-01"	4.245901639344262	"Crit Care"	2021	"10.1186/s13054-021-03842-9"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Impact of rewarming rate on interleukin-6 levels in patients with shockable cardiac arrest receiving targeted temperature management at 33 °C: the ISOCRATE pilot randomized controlled trial"	"Not used"
"Jaiswal 2019"	"https://clinicaltrials.gov/ct2/show/NCT02691013"	"Drug"	"3"	1	"(0,1]"	120	"(100,250]"	"No"	"2/2016-12/2017"	"2016-02-01"	"2017-12-01"	1.83013698630137	"Crit Care Med"	2019	"10.1097/CCM.0000000000004004"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Ramelteon for Prevention of Postoperative Delirium: A Randomized Controlled Trial in Patients Undergoing Elective Pulmonary Thromboendarterectomy"	"No reply"
"J-LAND 3S 2020"	"None"	"Drug"	"2b+3"	54	"(40,100]"	151	"(100,250]"	"No"	"1/2018-4/2019"	"2018-01-01"	"2019-04-01"	1.2465753424657535	"Lancet Respir Med"	2020	"10.1016/S2213-2600(20)30037-0"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial"	"No reply"
"Klarin 2018"	"https://clinicaltrials.gov/ct2/show/NCT01105819"	"Drug"	"3"	3	"(1,5]"	150	"(100,250]"	"No"	"1/2004-1/2015"	"2004-01-01"	"2015-01-01"	11	"Crit Care"	2018	"10.1186/s13054-018-2209-4"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Can probiotics be an alternative to chlorhexidine for oral care in the mechanically ventilated patient? A multicentre, prospective, randomised controlled open trial"	"No reply"
"Kredentser 2018"	"https://clinicaltrials.gov/ct2/show/NCT02067559"	"Management"	"Not drug trial"	1	"(0,1]"	58	"(0,100]"	"No"	"5/2014-11/2016"	"2014-05-01"	"2016-11-01"	2.504109589041096	"Crit Care Med"	2018	"10.1097/CCM.0000000000003367"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Preventing Posttraumatic Stress in ICU Survivors: A Single-Center Pilot Randomized Controlled Trial of ICU Diaries and Psychoeducation"	"No reply"
"Magic Bullet study 2019"	"https://clinicaltrials.gov/ct2/show/NCT01292031"	"Drug"	"3"	32	"(20,40]"	235	"(100,250]"	"No"	"5/2012-10/2015"	"2012-05-01"	"2015-10-01"	3.418032786885246	"Crit Care"	2019	"10.1186/s13054-019-2627-y"	"No"	"Yes"	"No"	"Potential harm (nephrotoxicity) in colistin arm."	"Safety"	"Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial"	"No reply"
"McNelly 2020"	"https://clinicaltrials.gov/ct2/show/NCT02358512"	"Drug"	"2"	8	"(5,10]"	127	"(100,250]"	"No"	"2/2015-9/2017"	"2015-02-01"	"2017-09-01"	2.580821917808219	"Chest"	2020	"10.1016/j.chest.2020.03.045"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Intermittent or Continuous Feed on Muscle Wasting in Critical Illness: A Phase 2 Clinical Trial"	"Not used"
"NONSEDA 2020"	"https://clinicaltrials.gov/ct2/show/NCT01967680"	"Drug"	"4"	8	"(5,10]"	710	"(500,1000]"	"No"	"1/2014-11/2017"	"2014-01-01"	"2017-11-01"	3.8328767123287673	"NEJM"	2020	"10.1056/NEJMoa1906759"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Nonsedation or Light Sedation in Critically Ill, Mechanically Ventilated Patients"	"No reply"
"NUTRIREA-2 2018"	"https://clinicaltrials.gov/ct2/show/NCT01802099"	"Drug"	"4"	44	"(40,100]"	2410	"(2000,5000]"	"No"	"3/2013-6/2015"	"2013-03-01"	"2015-06-01"	2.251366120218579	"Lancet"	2018	"10.1016/S0140-6736(17)32146-3"	"Yes"	"Yes"	"No"	"Futility"	"Futility"	"Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2)"	"No reply"
"Park 2019"	"None"	"Drug"	"3"	1	"(0,1]"	360	"(250,500]"	"No"	"10/2014-12/2016"	"2014-10-01"	"2016-12-01"	2.1671232876712327	"Crit Care Med"	2019	"10.1097/CCM.0000000000003900"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Lactated Ringer’s Versus 4% Albumin on Lactated Ringer’s in Early Sepsis Therapy in Cancer Patients: A Pilot Single-Center Randomized Trial"	"No reply"
"PEPTIC 2020"	"None"	"Drug"	"3+4"	50	"(40,100]"	26982	"(5000,26982]"	"No"	"8/2016-1/2019"	"2016-08-01"	"2019-01-01"	2.419178082191781	"JAMA"	2020	"10.1001/jama.2019.22190"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitorsvs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation - The PEPTIC Randomized Clinical Trial"	"Not used"
"Perkins 2018"	"https://www.isrctn.com/ISRCTN15635197"	"Management"	"Not drug trial"	41	"(40,100]"	364	"(250,500]"	"No"	"3/2013-10/2016"	"2013-03-01"	"2016-10-01"	3.5863013698630137	"JAMA"	2018	"10.1001/jama.2018.13763"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Protocolized Weaning With Early Extubation to Noninvasive Ventilation vs Invasive Weaning on Time to Liberation From Mechanical Ventilation Among Patients With Respiratory Failure - The Breathe Randomized Clinical Trial"	"No reply"
"POLAR 2018"	"https://clinicaltrials.gov/ct2/show/NCT00987688"	"Management"	"Not drug trial"	14	"(10,20]"	511	"(500,1000]"	"No"	"12/2010-11/2017"	"2010-12-01"	"2017-11-01"	6.917808219178082	"JAMA"	2018	"10.1001/jama.2018.17075"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury - The POLAR Randomized Clinical Trial"	"No reply"
"POSA-FLU 2021"	"https://clinicaltrials.gov/ct2/show/NCT03378479"	"Drug"	"4"	12	"(10,20]"	88	"(0,100]"	"No"	"12/2017-3/2020"	"2017-12-01"	"2020-03-01"	2.248633879781421	"Intensive Care Med"	2021	"10.1007/s00134-021-06431-0"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Posaconazole for prevention of invasive  pulmonary aspergillosis in critically ill infuenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial"	"No reply"
"PrePARE 2019"	"https://clinicaltrials.gov/ct2/show/NCT03026777"	"Drug"	"4"	9	"(5,10]"	337	"(250,500]"	"No"	"2/2017-1/2018"	"2017-02-01"	"2018-01-01"	0.915068493150685	"Lancet Respir Med"	2019	"10.1016/S2213-2600(19)30246-2"	"No"	"Yes"	"Yes"	"Futility"	"Futility"	"Effect of a fluid bolus on cardiovascular collapse among critically ill adults undergoing tracheal intubation (PrePARE): a randomised controlled trial"	"No reply"
"PReVENT 2018"	"https://clinicaltrials.gov/ct2/show/NCT02153294"	"Management"	"Not drug trial"	6	"(5,10]"	961	"(500,1000]"	"No"	"9/2014-8/2017"	"2014-09-01"	"2017-08-01"	2.915068493150685	"JAMA"	2018	"10.1001/jama.2018.14280"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS A Randomized Clinical Trial"	"No reply"
"ProCESS 2014"	"https://clinicaltrials.gov/ct2/show/NCT00510835"	"Management"	"Not drug trial"	31	"(20,40]"	1351	"(1000,2000]"	"No"	"3/2008-5/2013"	"2008-03-01"	"2013-05-01"	5.167123287671233	"NEJM"	2014	"10.1056/NEJMoa1401602"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"A Randomized Trial of Protocol-Based Care for Early Septic Shock"	"Not used"
"Pro-MEDIC 2022"	"ANZCTR/ACTRN12616000436471"	"Drug"	"2+3"	12	"(10,20]"	847	"(500,1000]"	"No"	"7/2016-9/2019"	"2016-07-01"	"2019-09-01"	3.169398907103825	"Intensive Care Med"	2022	"10.1007/s00134-022-06638-9"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): a randomized  controlled trial"	"No reply"
"PROMOTE 2019"	"None"	"Drug"	"2"	20	"(10,20]"	120	"(100,250]"	"No"	"10/2016-3/2018"	"2016-10-01"	"2018-03-01"	1.4136986301369863	"Intensive Care Med"	2019	"10.1007/s00134-019-05593-2"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial"	"No reply"
"PROPER 2021"	"https://clinicaltrials.gov/ct2/show/NCT03288311"	"Management"	"Not drug trial"	2	"(1,5]"	751	"(500,1000]"	"No"	"10/2017-3/2019"	"2017-10-01"	"2019-03-01"	1.4136986301369863	"Am J Respir Crit Care Med"	2021	"10.1164/rccm.202009-3561OC"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Protocolized Post-Extubation Respiratory Support to Prevent Reintubation: A Randomized Clinical Trial"	"Not used"
"ROCIT 2021"	"None"	"Drug"	"2"	5	"(1,5]"	221	"(100,250]"	"No"	"7/2017-12/2019"	"2017-07-01"	"2019-12-01"	2.418032786885246	"Intensive Care Med"	2021	"10.1007/s00134-020-06322-w"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Early and sustained Lactobacillus plantarum probiotic therapy in critical illness: the randomised, placebo-controlled, restoration of gut microflora in critical illness trial (ROCIT)"	"No reply"
"Schujmann 2019"	"None"	"Management"	"Not drug trial"	1	"(0,1]"	135	"(100,250]"	"No"	"2/2017-2/2018"	"2017-02-01"	"2018-02-01"	1	"Crit Care Med"	2019	"10.1097/CCM.0000000000004181"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Impact of a Progressive Mobility Program on the Functional Status, Respiratory, and Muscular Systems of ICU Patients: A Randomized and Controlled Trial"	"No reply"
"SCOPE-DKA 2021"	"ANZCTR/12618001622291"	"Drug"	"2"	7	"(5,10]"	93	"(0,100]"	"No"	"9/2019-9/2020"	"2019-09-01"	"2020-09-01"	1	"Intensive Care Med"	2021	"10.1007/s00134-021-06480-5"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Sodium chloride or Plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): a cluster, crossover, randomized, controlled trial"	"Not used"
"SEPSIS-ACT 2019"	"https://clinicaltrials.gov/ct2/show/NCT02508649"	"Drug"	"2b+3"	63	"(40,100]"	868	"(500,1000]"	"No"	"7/2015-8/2017"	"2015-07-01"	"2017-08-01"	2.084931506849315	"JAMA"	2019	"10.1001/jama.2019.14607"	"No"	"Yes"	"Yes"	"Futility"	"Futility"	"Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial"	"Not used"
"SMART 2018"	"https://clinicaltrials.gov/ct2/show/NCT02444988, https://clinicaltrials.gov/ct2/show/NCT02547779"	"Drug"	"4"	5	"(1,5]"	15802	"(5000,26982]"	"No"	"6/2015-4/2017"	"2015-06-01"	"2017-04-01"	1.8328767123287673	"NEJM"	2018	"10.1056/NEJMoa1711584"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Balanced Crystalloids versus Saline in Critically Ill Adults"	"No reply"
"Srisawat 2018"	"https://clinicaltrials.gov/ct2/show/NCT02413541"	"Drug"	"2"	5	"(1,5]"	60	"(0,100]"	"No"	"2/2014-7/2017"	"2014-02-01"	"2017-07-01"	3.410958904109589	"Crit Care"	2018	"10.1186/s13054-018-2077-y"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients"	"No reply"
"STOP-AKI 2018"	"https://clinicaltrials.gov/ct2/show/NCT02182440"	"Drug"	"2a+2b"	53	"(40,100]"	301	"(250,500]"	"No"	"12/2014-5/2017"	"2014-12-01"	"2017-05-01"	2.4136986301369863	"JAMA"	2018	"10.1001/jama.2018.14283"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury A Randomized Clinical Trial"	"No reply"
"STROMA-CoV-2 2022"	"https://clinicaltrials.gov/ct2/show/NCT04333368"	"Drug"	"2b"	10	"(5,10]"	47	"(0,100]"	"Yes"	"4/2020-10/2020"	"2020-04-01"	"2020-10-01"	0.5013698630136987	"Crit Care"	2022	"10.1186/s13054-022-03930-4"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial"	"No reply"
"Subira 2019"	"https://clinicaltrials.gov/ct2/show/NCT02620358"	"Management"	"Not drug trial"	18	"(10,20]"	1153	"(1000,2000]"	"No"	"1/2016-4/2017"	"2016-01-01"	"2017-04-01"	1.2465753424657535	"JAMA"	2019	"10.1001/jama.2019.7234"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Pressure Support vs T-Piece Ventilation Strategies During Spontaneous Breathing Trials on Successful Extubation Among Patients Receiving Mechanical Ventilation A Randomized Clinical Trial"	"Not used"
"SUP-ICU 2018"	"https://clinicaltrials.gov/ct2/show/NCT02467621"	"Drug"	"4"	33	"(20,40]"	3350	"(2000,5000]"	"No"	"1/2016-10/2017"	"2016-01-01"	"2017-10-01"	1.7479452054794522	"NEJM"	2018	"10.1056/NEJMoa1714919"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU"	"Not used"
"TARGET 2018"	"https://clinicaltrials.gov/ct2/show/NCT02306746"	"Drug"	"3"	46	"(40,100]"	3997	"(2000,5000]"	"No"	"6/2016-11/2017"	"2016-06-01"	"2017-11-01"	1.4191780821917808	"NEJM"	2018	"10.1056/NEJMoa1811687"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Energy-Dense versus Routine Enteral Nutrition in the Critically Ill"	"Not used"
"TELSTAR 2022"	"https://clinicaltrials.gov/ct2/show/NCT02056236"	"Drug"	"3"	11	"(10,20]"	179	"(100,250]"	"No"	"5/2014-1/2021"	"2014-05-01"	"2021-01-01"	6.671232876712329	"NEJM"	2022	"10.1056/NEJMoa2115998"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Treating Rhythmic and Periodic EEG Patterns in Comatose Survivors of Cardiac Arrest"	"Not used"
"TRANSFUSE 2017"	"None"	"Drug"	"3"	59	"(40,100]"	4994	"(2000,5000]"	"No"	"11/2012-12/2016"	"2012-11-01"	"2016-12-01"	4.082191780821918	"NEJM"	2017	"10.1056/NEJMoa1707572"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults"	"No reply"
"TRICS III 2017"	"https://clinicaltrials.gov/ct2/show/NCT02042898"	"Management"	"Not drug trial"	73	"(40,100]"	5243	"(5000,26982]"	"No"	"1/2014-3/2017"	"2014-01-01"	"2017-03-01"	3.1616438356164385	"NEJM"	2017	"10.1056/NEJMoa1711818"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery"	"Not used"
"TTM 2013"	"https://clinicaltrials.gov/ct2/show/NCT01020916"	"Management"	"Not drug trial"	36	"(20,40]"	950	"(500,1000]"	"No"	"11/2010-1/2013"	"2010-11-01"	"2013-01-01"	2.1671232876712327	"NEJM"	2013	"10.1056/NEJMoa1310519"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest"	"Not used"
"VAPORISE 2020"	"None"	"Drug"	"4"	1	"(0,1]"	26	"(0,100]"	"No"	"3/2015-3/2020"	"2015-03-01"	"2020-03-01"	5	"Intensive Care Med"	2020	"10.1007/s00134-019-05914-5"	"No"	"Yes"	"No"	"Insufficient inclusion"	"Slow enrolment"	"Effect of adjunctive tobramycin inhalation versus placebo on early clinical response in the treatment of ventilator-associated pneumonia: the VAPORISE randomized-controlled trial"	"Not used"
"VICTAS 2021"	"https://clinicaltrials.gov/ct2/show/NCT03509350"	"Drug"	"3"	43	"(40,100]"	501	"(500,1000]"	"No"	"8/2018-7/2019"	"2018-08-01"	"2019-07-01"	0.915068493150685	"JAMA"	2021	"10.1001/jama.2020.24505"	"No"	"Yes"	"No"	"Lack of funding"	"Funding exhausted"	"Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilatorand Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial"	"No reply"
"VITAMINS 2020"	"https://clinicaltrials.gov/ct2/show/NCT03333278"	"Drug"	"2"	10	"(5,10]"	216	"(100,250]"	"No"	"5/2018-7/2019"	"2018-05-01"	"2019-07-01"	1.1666666666666667	"JAMA"	2020	"10.1001/jama.2019.22176"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock The VITAMINS Randomized Clinical Trial"	"Not used"
"VITdAL-ICU 2014"	"None"	"Drug"	"3"	5	"(1,5]"	492	"(250,500]"	"No"	"5/2010-9/2012"	"2010-05-01"	"2012-09-01"	2.336986301369863	"JAMA"	2014	"10.1001/jama.2014.13204"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of High-Dose Vitamin D3 on Hospital Length of Stay in Critically Ill Patients With Vitamin D Deficiency The VITdAL-ICU Randomized Clinical Trial"	"No reply to clarification"
"65 trial 2020"	"https://www.isrctn.com/ISRCTN10580502"	"Management"	"Not drug trial"	65	"(40,100]"	2598	"(2000,5000]"	"No"	"7/2017-3/2019"	"2017-07-01"	"2019-03-01"	1.6657534246575343	"JAMA"	2020	"10.1001/jama.2020.0930"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension A Randomized Clinical Trial"	"Not used"
"ACIdoSIS 2021"	"https://clinicaltrials.gov/ct2/show/NCT02442440"	"Drug"	"1+2"	12	"(10,20]"	355	"(250,500]"	"No"	"5/2015-10/2020"	"2015-05-01"	"2020-10-01"	5.419178082191781	"Crit Care"	2021	"10.1186/s13054-021-03774-4"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Efectiveness of anisodamine for the treatment of critically ill patients with septic shock: a multicentre randomized controlled trial"	"Not used"
"ACTS 2020"	"https://clinicaltrials.gov/ct2/show/NCT03389555"	"Drug"	"2+3"	14	"(10,20]"	205	"(100,250]"	"No"	"2/2018-10/2019"	"2018-02-01"	"2019-10-01"	1.6630136986301371	"JAMA"	2020	"10.1001/jama.2020.11946"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock The ACTS Randomized Clinical Trial"	"No reply"
"AdrenOSS-2 2021"	"https://clinicaltrials.gov/ct2/show/NCT03085758"	"Drug"	"2a"	30	"(20,40]"	301	"(250,500]"	"No"	"12/2017-9/2019"	"2017-12-01"	"2019-09-01"	1.7506849315068493	"Intensive Care Med"	2021	"10.1007/s00134-021-06537-5"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial"	"Not used"
"ALBIOS 2014"	"https://clinicaltrials.gov/ct2/show/NCT00707122"	"Drug"	"3"	100	"(40,100]"	1818	"(1000,2000]"	"No"	"8/2008-2/2012"	"2008-08-01"	"2012-02-01"	3.5027322404371586	"NEJM"	2014	"10.1056/NEJMoa1305727"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Albumin Replacement in Patients with Severe Sepsis or Septic Shock"	"No reply"
"ANDROMEDA SHOCK 2019"	"https://clinicaltrials.gov/ct2/show/NCT03078712"	"Management"	"Not drug trial"	28	"(20,40]"	424	"(250,500]"	"No"	"3/2017-3/2018"	"2017-03-01"	"2018-03-01"	1	"JAMA"	2019	"10.1001/jama.2019.0071"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock The ANDROMEDA-SHOCK Randomized Clinical Trial"	"No reply"
"Arabi 2020"	"https://clinicaltrials.gov/ct2/show/NCT02845843"	"Drug"	"2+3"	19	"(10,20]"	95	"(0,100]"	"No"	"11/2016-4/2020"	"2016-11-01"	"2020-04-01"	3.4153005464480874	"NEJM"	2020	"10.1056/NEJMoa2015294"	"No"	"Yes"	"No"	"Due to COVID19 pandemic (efficacy boundaries not met)"	"COVID-19"	"Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome"	"No reply"
"ARISE 2014"	"https://clinicaltrials.gov/ct2/show/NCT00975793"	"Management"	"Not drug trial"	51	"(40,100]"	1600	"(1000,2000]"	"No"	"10/2008-4/2014"	"2008-10-01"	"2014-04-01"	5.498630136986302	"NEJM"	2014	"10.1056/NEJMoa1404380"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Goal-Directed Resuscitation for Patients with Early Septic Shock"	"Not used"
"ATHOS-3 2017"	"https://clinicaltrials.gov/ct2/show/NCT02338843"	"Drug"	"3"	75	"(40,100]"	344	"(250,500]"	"No"	"5/2015-1/2017"	"2015-05-01"	"2017-01-01"	1.6712328767123288	"NEJM"	2017	"10.1056/NEJMoa1704154"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Angiotensin II for the Treatment of Vasodilatory Shock"	"Not used"
"Barrett 2022"	"https://clinicaltrials.gov/ct2/show/NCT04357730"	"Drug"	"2a"	8	"(5,10]"	50	"(0,100]"	"Yes"	"5/2020-3/2021"	"2020-05-01"	"2021-03-01"	0.8328767123287671	"Chest"	2022	"10.1016/j.chest.2021.09.024"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial"	"No reply"
"Benitez-Cano 2020"	"None"	"Drug"	"4"	1	"(0,1]"	31	"(0,100]"	"No"	"1/2017-2/2019"	"2017-01-01"	"2019-02-01"	2.084931506849315	"Crit Care"	2020	"10.1186/s13054-020-2763-4"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial"	"Not used"
"BREATHE 2022"	"https://clinicaltrials.gov/ct2/show/NCT04351243"	"Drug"	"2"	21	"(20,40]"	227	"(100,250]"	"Yes"	"4/2020-10/2020"	"2020-04-01"	"2020-10-01"	0.5013698630136987	"Am J Respir Crit Care Med"	2022	"10.1164/rccm.202108-1859OC"	"No"	"Yes"	"Yes"	"Futility"	"Futility"	"Anti-GM-CSF Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-Controlled Trial"	"No reply"
"Campos 2022"	"None"	"Management"	"Not drug trial"	1	"(0,1]"	139	"(100,250]"	"No"	"7/2018-12/2019"	"2018-07-01"	"2019-12-01"	1.418032786885246	"Crit Care Med"	2022	"10.1097/CCM.0000000000005557"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Early Neuromuscular Electrical Stimulation in Addition to Early Mobilization Improves Functional Status and Decreases Hospitalization Days of Critically Ill Patients"	"No reply"
"CAPE COVID 2020"	"https://clinicaltrials.gov/ct2/show/NCT02517489"	"Drug"	"3"	9	"(5,10]"	149	"(100,250]"	"Yes"	"3/2020-6/2020"	"2020-03-01"	"2020-06-01"	0.25205479452054796	"JAMA"	2020	"10.1001/jama.2020.16761"	"No"	"Yes"	"No"	"Potential loss of equipoise (dexamethasone trial published)"	"Loss of equipoise"	"Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19 A Randomized Clinical Trial"	"No reply"
"CASS 2018"	"https://clinicaltrials.gov/ct2/show/NCT01455116"	"Management"	"Not drug trial"	10	"(5,10]"	436	"(250,500]"	"No"	"11/2011-11/2016"	"2011-11-01"	"2016-11-01"	5	"Lancet Respir Med"	2018	"10.1016/S2213-2600(18)30004-3"	"No"	"Yes"	"Yes"	"Futility"	"Futility"	"Induced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trial"	"Not used"
"Chang 2020"	"https://clinicaltrials.gov/ct2/show/NCT03258684"	"Drug"	"3"	1	"(0,1]"	80	"(0,100]"	"No"	"9/2017-1/2019"	"2017-09-01"	"2019-01-01"	1.3342465753424657	"Chest"	2020	"10.1016/j.chest.2020.02.065"	"No"	"Yes"	"Yes"	"High incidence of severe hypernatremia (> 160 mmol/L) and ineffectiveness of the combined treatment protocol"	"Safety"	"Combined Treatment With Hydrocortisone, Vitamin C, and Thiamine for Sepsis and Septic Shock A Randomized Controlled Trial"	"No reply"
"CHARLI 2021"	"None"	"Drug"	"3"	9	"(5,10]"	256	"(250,500]"	"No"	"9/2012-8/2018"	"2012-09-01"	"2018-08-01"	5.9150684931506845	"Lancet Respir Med"	2021	"10.1016/S2213-2600(20)30470-7"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial"	"No reply"
"Check-UP 2018"	"https://clinicaltrials.gov/ct2/show/NCT02497729"	"Management"	"Not drug trial"	5	"(1,5]"	267	"(250,500]"	"No"	"7/2015-7/2016"	"2015-07-01"	"2016-07-01"	1	"Chest"	2018	"10.1016/j.chest.2017.08.1163"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"A Multicenter Randomized Trial of a Checklist for Endotracheal Intubation of Critically Ill Adults"	"No reply"
"Chlan 2014"	"https://clinicaltrials.gov/ct2/show/NCT00440700"	"Device"	"Not drug trial"	12	"(10,20]"	373	"(250,500]"	"No"	"9/2006-3/2011"	"2006-09-01"	"2011-03-01"	4.495890410958904	"JAMA"	2014	"10.1001/jama.2013.5670"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effects of patient-directed music intervention on anxiety and sedative exposure in critically ill patients receiving mechanical ventilatory support: a randomized clinical trial"	"No reply"
"CIGMA 2018"	"https://clinicaltrials.gov/ct2/show/NCT01420744"	"Drug"	"2"	24	"(20,40]"	160	"(100,250]"	"No"	"10/2011-2/2015"	"2011-10-01"	"2015-02-01"	3.336986301369863	"Intensive Care Med"	2018	"10.1007/s00134-018-5143-7"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)"	"Not used"
"COBI 2021"	"https://clinicaltrials.gov/ct2/show/NCT03143751"	"Drug"	"3"	9	"(5,10]"	370	"(250,500]"	"No"	"10/2017-8/2019"	"2017-10-01"	"2019-08-01"	1.8328767123287673	"JAMA"	2021	"10.1001/jama.2021.5561"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Continuous Infusion of Hypertonic Saline vs Standard Care on 6-Month Neurological Outcomes in Patients With Traumatic Brain Injury The COBI Randomized Clinical Trial"	"No reply"
"CO-ILEPSS 2019"	"https://clinicaltrials.gov/ct2/show/NCT02204852"	"Drug"	"2a"	1	"(0,1]"	24	"(0,100]"	"No"	"10/2014-5/2016"	"2014-10-01"	"2016-05-01"	1.581967213114754	"Crit Care"	2019	"10.1186/s13054-019-2573-8"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Co-administration of iloprost and eptifibatide in septic shock (CO-ILEPSS)—a randomised, controlled, double-blind investigator-initiated trial investigating safety and efficacy"	"Not used"
"CONTROLING 2021"	"https://clinicaltrials.gov/ct2/show/NCT02244073"	"Management"	"Not drug trial"	12	"(10,20]"	2075	"(2000,5000]"	"No"	"5/2015-7/2016"	"2015-05-01"	"2016-07-01"	1.167123287671233	"Intensive Care Med"	2021	"10.1007/s00134-021-06526-8"	"No"	"Yes"	"Yes"	"Safety and futility"	"Safety"	"Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study—a randomized clinical trial"	"No reply"
"Corti-TC 2014"	"None"	"Drug"	"3"	19	"(10,20]"	336	"(250,500]"	"No"	"9/2010-11/2012"	"2010-09-01"	"2012-11-01"	2.1671232876712327	"Lancet Respir Med"	2014	"10.1016/S2213-2600(14)70144-4"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial"	"No reply"
"COV-AID 2021"	"https://clinicaltrials.gov/ct2/show/NCT04330638"	"Drug"	"3"	16	"(10,20]"	342	"(250,500]"	"Yes"	"4/2020-12/2020"	"2020-04-01"	"2020-12-01"	0.6684931506849315	"Lancet Respir Med"	2021	"10.1016/S2213-2600(21)00377-5"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial"	"Not used"
"COV-BARRIER 2022"	"https://clinicaltrials.gov/ct2/show/NCT04421027"	"Drug"	"3"	18	"(10,20]"	101	"(100,250]"	"Yes"	"12/2020-4/2021"	"2020-12-01"	"2021-04-01"	0.3315068493150685	"Lancet Respir Med"	2022	"10.1016/S2213-2600(22)00006-6"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial"	"No reply"
"COVID STEROID 2 2021"	"https://clinicaltrials.gov/ct2/show/NCT04509973"	"Drug"	"3"	31	"(20,40]"	1000	"(500,1000]"	"Yes"	"8/2020-5/2021"	"2020-08-01"	"2021-05-01"	0.7479452054794521	"JAMA"	2021	"10.1001/jama.2021.18295"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia The COVID STEROID 2 Randomized Trial"	"Not used"
"COVINTOC 2021"	"None"	"Drug"	"3"	12	"(10,20]"	180	"(100,250]"	"Yes"	"5/2020-8/2020"	"2020-05-01"	"2020-08-01"	0.25205479452054796	"Lancet Respir Med"	2021	"10.1016/S2213-2600(21)00081-3"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19- associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial"	"No reply"
"CYCOV 2021"	"https://clinicaltrials.gov/ct2/show/NCT04324528"	"Device"	"Not drug trial"	1	"(0,1]"	34	"(0,100]"	"Yes"	"3/2020-12/2020"	"2020-03-01"	"2020-12-01"	0.7534246575342466	"Lancet Respir Med"	2021	"10.1016/S2213-2600(21)00177-6"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial"	"Not used"
"CytoResc 2022"	"None"	"Device"	"Not drug trial"	3	"(1,5]"	50	"(0,100]"	"Yes"	"11/2020-3/2021"	"2020-11-01"	"2021-03-01"	0.3287671232876712	"Crit Care Med"	2022	"10.1097/CCM.0000000000005493"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"CytoSorb Rescue for COVID-19 Patients With Vasoplegic Shock and Multiple Organ Failure: A Prospective, Open-Label, Randomized Controlled Pilot Study"	"No reply"
"Dadam 2021"	"None"	"Management"	"Not drug trial"	4	"(1,5]"	336	"(250,500]"	"No"	"8/2018-7/2019"	"2018-08-01"	"2019-07-01"	0.915068493150685	"Chest"	2021	"10.1016/j.chest.2021.02.064"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"The Effect of Reconnection to Mechanical Ventilation for 1 Hour After Spontaneous Breathing Trial on Reintubation Among Patients Ventilated for More Than 12 Hours: A Randomized Clinical Trial"	"No reply"
"deVries 2022"	"None"	"Management"	"Not drug trial"	1	"(0,1]"	40	"(0,100]"	"No"	"4/2018-7/2020"	"2018-04-01"	"2020-07-01"	2.249315068493151	"Crit Care Med"	2022	"10.1097/CCM.0000000000005395"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Lung- and Diaphragm-Protective Ventilation by Titrating Inspiratory Support to Diaphragm Effort: A Randomized Clinical Trial"	"Not used"
"DEXACET 2019"	"https://clinicaltrials.gov/ct2/show/NCT02546765"	"Drug"	"4"	1	"(0,1]"	121	"(100,250]"	"No"	"9/2015-4/2018"	"2015-09-01"	"2018-04-01"	2.580821917808219	"JAMA"	2019	"10.1001/jama.2019.0234"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Intravenous Acetaminophen vs Placebo Combined With Propofol or Dexmedetomidine on Postoperative Delirium Among Older Patients Following Cardiac Surgery The DEXACET Randomized Clinical Trial"	"No reply"
"DOREMI 2021"	"https://clinicaltrials.gov/ct2/show/NCT03207165"	"Drug"	"4"	1	"(0,1]"	192	"(100,250]"	"No"	"9/2017-5/2020"	"2017-09-01"	"2020-05-01"	2.663934426229508	"NEJM"	2021	"10.1056/NEJMoa2026845"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock"	"No reply"
"Douglas 2010"	"https://clinicaltrials.gov/ct2/show/NCT02837731"	"Management"	"Not drug trial"	13	"(10,20]"	150	"(100,250]"	"No"	"10/2016-2/2019"	"2016-10-01"	"2019-02-01"	2.336986301369863	"Chest"	2020	"10.1016/j.chest.2020.04.025"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Fluid Response Evaluation in Sepsis Hypotension and Shock: A Randomized Clinical Trial"	"Not used"
"DOVSS 2018"	"https://clinicaltrials.gov/ct2/show/NCT01493102"	"Drug"	"4"	1	"(0,1]"	85	"(0,100]"	"No"	"1/2012-2/2014"	"2012-01-01"	"2014-02-01"	2.084931506849315	"Crit Care"	2018	"10.1186/s13054-018-2034-9"	"No"	"Yes"	"Yes"	"'a significant difference between the two groups in the incidence of hypotension during the first vasopressor tapering' (p. 4)"	"Safety"	"Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)"	"No reply"
"Drewry 2022"	"None"	"Management"	"Not drug trial"	1	"(0,1]"	56	"(0,100]"	"No"	"3/2016-4/2019"	"2016-03-01"	"2019-04-01"	3.0846994535519126	"Crit Care Med"	2022	"10.1097/CCM.0000000000005470"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Therapeutic Hyperthermia Is Associated With Improved Survival in Afebrile Critically Ill Patients With Sepsis: A Pilot Randomized Trial"	"No reply"
"DURAPOP 2018"	"https://clinicaltrials.gov/ct2/show/NCT01311765"	"Drug"	"3"	21	"(20,40]"	249	"(100,250]"	"No"	"5/2011-2/2015"	"2011-05-01"	"2015-02-01"	3.756164383561644	"Intensive Care Med"	2018	"10.1007/s00134-018-5088-x"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial"	"Not used"
"ECMO-PT 2020"	"https://clinicaltrials.gov/ct2/show/NCT03328767"	"Management"	"Not drug trial"	3	"(1,5]"	20	"(0,100]"	"No"	"2/2018-5/2019"	"2018-02-01"	"2019-05-01"	1.2438356164383562	"Intensive Care Med"	2020	"10.1007/s00134-020-05994-8"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Early mobilisation during extracorporeal membrane oxygenation was safe and feasible: a pilot randomised controlled trial"	"Not used"
"Ehrmann 2021"	"https://clinicaltrials.gov/ct2/show/NCT04477655, https://clinicaltrials.gov/ct2/show/NCT04358939, https://clinicaltrials.gov/ct2/show/NCT04395144, https://clinicaltrials.gov/ct2/show/NCT04325906, https://clinicaltrials.gov/ct2/show/NCT04391140, https://clinicaltrials.gov/ct2/show/NCT04347941"	"Management"	"Not drug trial"	42	"(40,100]"	1126	"(1000,2000]"	"Yes"	"4/2020-1/2021"	"2020-04-01"	"2021-01-01"	0.7534246575342466	"Lancet Respir Med"	2021	"10.1016/S2213-2600(21)00356-8"	"No"	"Yes"	"Yes"	"Efficacy"	"Efficacy/superiority"	"Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial"	"No reply"
"ETTS 2019"	"https://clinicaltrials.gov/ct2/show/NCT03760510"	"Management"	"Not drug trial"	1	"(0,1]"	500	"(250,500]"	"No"	"5/2017-4/2018"	"2017-05-01"	"2018-04-01"	0.9178082191780822	"Crit Care"	2019	"10.1186/s13054-019-2440-7"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"The effect of adhesive tape versus endotracheal tube fastener in critically ill adults: the endotracheal tube securement (ETTS) randomized controlled trial"	"No reply"
"EUPHRATES 2018"	"https://clinicaltrials.gov/ct2/show/NCT01046669"	"Drug"	"3"	55	"(40,100]"	450	"(250,500]"	"No"	"9/2010-6/2016"	"2010-09-01"	"2016-06-01"	5.748633879781421	"JAMA"	2018	"10.1001/jama.2018.14618"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level The EUPHRATES Randomized Clinical Trial"	"Not used"
"EvK Clinical Trial 2022"	"https://clinicaltrials.gov/ct2/show/NCT02643381"	"Drug"	"4"	1	"(0,1]"	801	"(500,1000]"	"No"	"6/2016-9/2020"	"2016-06-01"	"2020-09-01"	4.252054794520548	"Intensive Care Med"	2022	"10.1007/s00134-021-06577-x"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Etomidate versus ketamine for emergency endotracheal intubation: a randomized clinical trial"	"Not used"
"FLORALI-2 2019"	"https://clinicaltrials.gov/ct2/show/NCT02668458"	"Management"	"Not drug trial"	28	"(20,40]"	322	"(250,500]"	"No"	"4/2016-1/2017"	"2016-04-01"	"2017-01-01"	0.7534246575342466	"Lancet Respir Med"	2019	"10.1016/S2213-2600(19)30048-7"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial"	"No reply"
"FLORALI-IM 2022"	"https://clinicaltrials.gov/ct2/show/NCT02978300"	"Management"	"Not drug trial"	29	"(20,40]"	300	"(250,500]"	"No"	"1/2017-3/2019"	"2017-01-01"	"2019-03-01"	2.1616438356164385	"Lancet Respir Med"	2022	"10.1016/S2213-2600(22)00096-0"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial"	"No reply"
"Fluids After Bypass Study 2021"	"None"	"Drug"	"3"	5	"(1,5]"	715	"(500,1000]"	"No"	"11/2016-12/2018"	"2016-11-01"	"2018-12-01"	2.0821917808219177	"Crit Care Med"	2021	"10.1097/CCM.0000000000004883"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"A Multicenter, Open-Label, Randomized Controlled Trial of a Conservative Fluid Management Strategy Compared With Usual Care in Participants After Cardiac Surgery: The Fluids After Bypass Study"	"Not used"
"Fossat 2018"	"https://clinicaltrials.gov/ct2/show/NCT02185989"	"Management"	"Not drug trial"	1	"(0,1]"	314	"(250,500]"	"No"	"7/2014-6/2016"	"2014-07-01"	"2016-06-01"	1.918032786885246	"JAMA"	2018	"10.1001/jama.2018.9592"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of In-Bed Leg Cycling and Electrical Stimulation of the Quadriceps on Global Muscle Strength in Critically Ill Adults A Randomized Clinical Trial"	"Not used"
"Francois 2018"	"None"	"Drug"	"1+2a"	13	"(10,20]"	48	"(0,100]"	"No"	"5/2012-5/2016"	"2012-05-01"	"2016-05-01"	4	"Intensive Care Med"	2018	"10.1007/s00134-018-5229-2"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial"	"Not used"
"Garrouste-Orgeas 2019"	"https://clinicaltrials.gov/ct2/show/NCT02519725"	"Management"	"Not drug trial"	35	"(20,40]"	657	"(500,1000]"	"No"	"10/2015-1/2017"	"2015-10-01"	"2017-01-01"	1.252054794520548	"JAMA"	2019	"10.1001/jama.2019.9058"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of an ICU Diary on Posttraumatic Stress Disorder Symptoms Among Patients Receiving Mechanical Ventilation A Randomized Clinical Trial"	"No reply"
"Gelissen 2021"	"https://clinicaltrials.gov/ct2/show/NCT02321072"	"Drug"	"4"	4	"(1,5]"	574	"(500,1000]"	"No"	"2/2015-10/2018"	"2015-02-01"	"2018-10-01"	3.663013698630137	"JAMA"	2021	"10.1001/jama.2021.13011"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Low-Normal vs High-Normal Oxygenation Targets on Organ Dysfunction in Critically Ill Patients"	"Not used"
"Georgevici 2021"	"https://clinicaltrials.gov/ct2/show/NCT03860129"	"Drug"	"4"	1	"(0,1]"	30	"(0,100]"	"No"	"12/2014-5/2017"	"2014-12-01"	"2017-05-01"	2.4136986301369863	"Crit Care"	2021	"10.1186/s13054-021-03556-y"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Negative drift of sedation depth in critically ill patients receiving constant minimum alveolar concentration of isoflurane, sevoflurane, or desflurane: a randomized controlled trial"	"No reply"
"Gobatto 2019"	"https://clinicaltrials.gov/ct2/show/NCT02203292"	"Drug"	"2"	2	"(1,5]"	47	"(0,100]"	"No"	"8/2014-6/2016"	"2014-08-01"	"2016-06-01"	1.8333333333333335	"Crit Care"	2019	"10.1186/s13054-018-2273-9"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Transfusion requirements after head trauma: a randomized feasibility controlled trial"	"Not used"
"Guimaraes 2021"	"https://clinicaltrials.gov/ct2/show/NCT02932189"	"Device"	"Not drug trial"	1	"(0,1]"	110	"(100,250]"	"No"	"1/2016-9/2018"	"2016-01-01"	"2018-09-01"	2.6657534246575345	"Crit Care Med"	2021	"10.1097/CCM.0000000000004787"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Inspiratory Muscle Training With an Electronic Resistive Loading Device Improves Prolonged Weaning Outcomes in a Randomized Controlled Trial"	"No reply"
"Hassan 2018"	"None"	"Drug"	"3"	1	"(0,1]"	133	"(100,250]"	"No"	"8/2014-8/2015"	"2014-08-01"	"2015-08-01"	1	"Crit Care Med"	2018	"10.1097/CCM.0000000000002695"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Nebulized Versus IV Amikacin as Adjunctive Antibiotic for Hospital and Ventilator-Acquired Pneumonia Postcardiac Surgeries: A Randomized Controlled Trial"	"No reply"
"He 2019"	"https://clinicaltrials.gov/ct2/show/NCT01581229"	"Management"	"Not drug trial"	21	"(20,40]"	204	"(100,250]"	"No"	"5/2012-6/2015"	"2012-05-01"	"2015-06-01"	3.0846994535519126	"Crit Care"	2019	"10.1186/s13054-019-2575-6"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"A multicenter RCT of noninvasive ventilation in pneumonia-induced early mild acute respiratory distress syndrome"	"No reply"
"HELP-ECMO 2019"	"ANZCTR/ACTRN12613001324707"	"Drug"	"1+2"	2	"(1,5]"	32	"(0,100]"	"No"	"4/2014-4/2016"	"2014-04-01"	"2016-04-01"	2	"Crit Care Med"	2019	"10.1097/CCM.0000000000003780"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Low-Dose Versus Therapeutic Anticoagulation in Patients on Extracorporeal Membrane Oxygenation: A Pilot Randomized Trial"	"No reply"
"HENIVOT 2021"	"https://clinicaltrials.gov/ct2/show/NCT04502576"	"Device"	"Not drug trial"	4	"(1,5]"	110	"(100,250]"	"Yes"	"10/2020-12/2020"	"2020-10-01"	"2020-12-01"	0.16712328767123288	"JAMA"	2021	"10.1001/jama.2021.4682"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Helmet Noninvasive Ventilation vs High-FlowNasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure The HENIVOT Randomized Clinical Trial"	"No reply"
"HiFLo-COVID 2021"	"https://clinicaltrials.gov/ct2/show/NCT04609462"	"Device"	"Not drug trial"	3	"(1,5]"	250	"(100,250]"	"Yes"	"8/2020-1/2021"	"2020-08-01"	"2021-01-01"	0.4191780821917808	"JAMA"	2021	"10.1001/jama.2021.20714"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19 A Randomized Clinical Trial"	"No reply"
"HIGH-WEAN 2018"	"https://clinicaltrials.gov/ct2/show/NCT03121482"	"Device"	"Not drug trial"	30	"(20,40]"	648	"(500,1000]"	"No"	"4/2017-1/2018"	"2017-04-01"	"2018-01-01"	0.7534246575342466	"JAMA"	2020	"10.1001/jama.2019.14901"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Postextubation High-Flow Nasal Oxygen With Noninvasive Ventilation vs High-Flow Nasal Oxygen Alone on Reintubation Among Patients at HighR isk of Extubation Failure A Randomized Clinical Tria"	"No reply"
"Hirshberg 2018"	"None"	"Management"	"Not drug trial"	4	"(1,5]"	52	"(0,100]"	"No"	"9/2011-10/2015"	"2011-09-01"	"2015-10-01"	4.081967213114754	"Crit Care Med"	2018	"10.1097/CCM.0000000000003437"	"No"	"Yes"	"No"	"'low enrollment and inability to consistently achieve tidal volumes less than 6.5 mL/kg in the low tidal volume-airway pressure release ventilation arm'"	"Slow enrolment + infeasibility"	"Randomized Feasibility Trial of a Low Tidal Volume-Airway Pressure Release Ventilation Protocol Compared With Traditional Airway Pressure Release Ventilation and Volume Control Ventilation Protocols"	"No reply"
"HYPO-ECMO 2022"	"https://clinicaltrials.gov/ct2/show/NCT02754193"	"Management"	"Not drug trial"	20	"(10,20]"	374	"(250,500]"	"No"	"10/2016-7/2019"	"2016-10-01"	"2019-07-01"	2.747945205479452	"JAMA"	2022	"10.1001/jama.2021.24776"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation A Randomized Clinical Trial"	"No reply"
"Ibarra-Estrada 2022"	"https://clinicaltrials.gov/ct2/show/NCT04221737"	"Device"	"Not drug trial"	1	"(0,1]"	101	"(100,250]"	"Yes"	"3/2020-11/2020"	"2020-03-01"	"2020-11-01"	0.6712328767123288	"Crit Care Med"	2022	"10.1097/CCM.0000000000005312"	"No"	"Yes"	"No"	"Potential harm (barotrauma, higher incidence of hypercapnia)"	"Safety"	"Use of Airway Pressure Release Ventilation in Patients With Acute Respiratory Failure Due to COVID-19: Results of a Single-Center Randomized Controlled Trial"	"Not used"
"ICAR 2022"	"https://clinicaltrials.gov/ct2/show/NCT04350580"	"Drug"	"3"	43	"(40,100]"	146	"(100,250]"	"Yes"	"4/2020-10/2020"	"2020-04-01"	"2020-10-01"	0.5013698630136987	"Lancet Respir Med"	2022	"10.1016/S2213-2600(21)00440-9"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Intravenous immunoglobulins in patients with COVID-19- associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo- controlled, phase 3 trial"	"Not used"
"ICU-ROX 2020"	"ANZCTR/ACTRN12615000957594"	"Drug"	"4"	21	"(20,40]"	1000	"(500,1000]"	"No"	"9/2015-5/2018"	"2015-09-01"	"2018-05-01"	2.663013698630137	"NEJM"	2020	"10.1056/NEJMoa1903297"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Conservative Oxygen Therapy during Mechanical Ventilation in the ICU"	"Not used"
"ICU Visits 2019"	"https://clinicaltrials.gov/ct2/show/NCT02932358"	"Management"	"Not drug trial"	36	"(20,40]"	1685	"(1000,2000]"	"No"	"4/2017-6/2018"	"2017-04-01"	"2018-06-01"	1.167123287671233	"JAMA"	2019	"10.1001/jama.2019.8766"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Flexible Family Visitation on Delirium Among Patients in the Intensive Care Unit The ICU Visits Randomized Clinical Trial"	"No reply"
"INSPIRATION-S 2022"	"https://clinicaltrials.gov/ct2/show/NCT04486508"	"Drug"	"3"	11	"(10,20]"	605	"(500,1000]"	"Yes"	"7/2020-4/2021"	"2020-07-01"	"2021-04-01"	0.7506849315068493	"BMJ"	2022	"10.1136/bmj-2021-068407"	"No"	"Yes"	"No"	"Lack of additional funding and the excessive burden of new enrollment to site investigators"	"Funding exhausted"	"Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial"	"No reply"
"Jonkman 2020"	"https://clinicaltrials.gov/ct2/show/NCT03453944"	"Device"	"Not drug trial"	3	"(1,5]"	20	"(0,100]"	"No"	"1/2017-1/2019"	"2017-01-01"	"2019-01-01"	2	"Crit Care"	2020	"10.1186/s13054-020-03352-0"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Breath-synchronized electrical stimulation of the expiratory muscles in mechanically ventilated patients: a randomized controlled feasibility study and pooled analysis"	"Not used"
"Kacmarek 2020"	"None"	"Management"	"Not drug trial"	15	"(10,20]"	310	"(250,500]"	"No"	"3/2014-10/2019"	"2014-03-01"	"2019-10-01"	5.584699453551913	"Intensive Care Med"	2020	"10.1007/s00134-020-06181-5"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Neurally adjusted ventilatory assist in acute respiratory failure: a randomized controlled trial"	"No reply"
"LaSRS 2006"	"None"	"Drug"	"3"	25	"(20,40]"	180	"(100,250]"	"No"	"8/1997-11/2003"	"1997-08-01"	"2003-11-01"	6.251366120218579	"NEJM"	2006	"10.1056/NEJMoa051693"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome"	"No reply"
"LeoPARDS 2016"	"None"	"Drug"	"4"	34	"(20,40]"	516	"(500,1000]"	"No"	"1/2014-12/2015"	"2014-01-01"	"2015-12-01"	1.915068493150685	"NEJM"	2016	"10.1056/NEJMoa1609409"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Levosimendan for the Prevention of Acute  Organ Dysfunction in Sepsis"	"Not used"
"Li 2018"	"None"	"Management"	"Not drug trial"	1	"(0,1]"	110	"(100,250]"	"No"	"10/2012-6/2016"	"2012-10-01"	"2016-06-01"	3.6666666666666665	"Crit Care Med"	2018	"10.1097/CCM.0000000000002826"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Treatment Outcome of Combined Continuous Venovenous Hemofiltration and Hemoperfusion in Acute Paraquat Poisoning: A Prospective Controlled Trial"	"No reply"
"Li 2020"	"None"	"Drug"	"3"	7	"(5,10]"	103	"(100,250]"	"Yes"	"2/2020-4/2020"	"2020-02-01"	"2020-04-01"	0.16393442622950818	"JAMA"	2020	"10.1001/jama.2020.10044"	"No"	"Yes"	"No"	"Slow enrolment due to containment strategy in catchment area"	"Slow enrolment"	"Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial"	"No reply"
"Liu 2018"	"https://clinicaltrials.gov/ct2/show/NCT01697410"	"Drug"	"4"	21	"(20,40]"	617	"(500,1000]"	"No"	"1/2013-2/2016"	"2013-01-01"	"2016-02-01"	3.0846994535519126	"Intensive Care Med"	2018	"10.1007/s00134-018-5267-9"	"No"	"Yes"	"Yes"	"Futility"	"Futility"	"Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial"	"No reply"
"LIVE 2019"	"https://clinicaltrials.gov/ct2/show/NCT02149589"	"Management"	"Not drug trial"	20	"(10,20]"	420	"(250,500]"	"No"	"6/2014-2/2017"	"2014-06-01"	"2017-02-01"	2.671232876712329	"Lancet Respir Med"	2019	"10.1016/S2213-2600(19)30138-9"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial"	"No reply"
"LOCO2 2020"	"https://clinicaltrials.gov/ct2/show/NCT02713451"	"Drug"	"3"	13	"(10,20]"	205	"(100,250]"	"No"	"6/2016-9/2018"	"2016-06-01"	"2018-09-01"	2.252054794520548	"NEJM"	2020	"10.1056/NEJMoa1916431"	"No"	"Yes"	"No"	"Safety concerns and likely futility"	"Safety"	"Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome"	"No reply"
"Longhini 2020"	"ANZCTR/ACTRN12615001257550"	"Management"	"Not drug trial"	1	"(0,1]"	60	"(0,100]"	"No"	"12/2015-6/2016"	"2015-12-01"	"2016-06-01"	0.5	"Crit Care"	2020	"10.1186/s13054-020-03198-6"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Chest physiotherapy improves lung aeration in hypersecretive critically ill patients: a pilot randomized physiological study"	"Not used"
"Ma 2019"	"https://clinicaltrials.gov/ct2/show/NCT03263143"	"Management"	"Not drug trial"	1	"(0,1]"	199	"(100,250]"	"No"	"8/2017-5/2018"	"2017-08-01"	"2018-05-01"	0.7479452054794521	"Crit Care Med"	2019	"10.1097/CCM.0000000000004016"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Early Palliative Care Consultation in the Medical ICU: A Cluster Randomized Crossover Trial"	"No reply"
"Martinez 2020"	"https://clinicaltrials.gov/ct2/show/NCT02512744"	"Management"	"Not drug trial"	5	"(1,5]"	330	"(250,500]"	"No"	"5/2016-5/2018"	"2016-05-01"	"2018-05-01"	2	"NEJM"	2020	"10.1056/NEJMoa2010834"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"High-Flow Oxygen with Capping or Suctioning for Tracheostomy Decannulation"	"No reply"
"McCaughey 2019"	"None"	"Device"	"Not drug trial"	1	"(0,1]"	20	"(0,100]"	"No"	"11/2017-4/2018"	"2017-11-01"	"2018-04-01"	0.4136986301369863	"Crit Care"	2019	"10.1186/s13054-019-2544-0"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Abdominal functional electrical stimulation to assist ventilator weaning in critical illness: a double-blinded, randomised, sham-controlled pilot study"	"Not used"
"MENDS2 2021"	"https://clinicaltrials.gov/ct2/show/NCT01739933"	"Drug"	"3"	13	"(10,20]"	432	"(250,500]"	"No"	"5/2013-12/2018"	"2013-05-01"	"2018-12-01"	5.586301369863014	"NEJM"	2021	"10.1056/NEJMoa2024922"	"No"	"Yes"	"No"	"Peri-trial reduction of required sample size; seems a nifty way to not have to stop early due to slow enrolment"	"Slow enrolment"	"Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis"	"Not used"
"MIDAS 2020"	"None"	"Drug"	"3"	3	"(1,5]"	136	"(100,250]"	"No"	"10/2012-6/2019"	"2012-10-01"	"2019-06-01"	6.6657534246575345	"Intensive Care Med"	2020	"10.1007/s00134-020-06216-x"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial"	"No reply"
"MIND-USA 2018"	"https://clinicaltrials.gov/ct2/show/NCT01211522"	"Drug"	"3"	16	"(10,20]"	566	"(500,1000]"	"No"	"12/2011-8/2017"	"2011-12-01"	"2017-08-01"	5.6657534246575345	"NEJM"	2018	"10.1056/NEJMoa1808217"	"Yes"	"Yes"	"No"	"Sample size modification post-hoc (6/2014, Itemized Protocol Changes as of 30 June 2014), reason not specified"	"Slow enrolment"	"Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness"	"Not used"
"MUST-ARDS 2022"	"https://clinicaltrials.gov/ct2/show/NCT02611609"	"Drug"	"1+2"	12	"(10,20]"	30	"(0,100]"	"No"	"3/2016-9/2018"	"2016-03-01"	"2018-09-01"	2.504109589041096	"Intensive Care Med"	2022	"10.1007/s00134-021-06570-4"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Safety and efcacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial"	"No reply"
"Nakanishi 2020"	"None"	"Device"	"Not drug trial"	2	"(1,5]"	42	"(0,100]"	"No"	"7/2017-1/2020"	"2017-07-01"	"2020-01-01"	2.5027322404371586	"Crit Care Med"	2020	"10.1097/CCM.0000000000004522"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Electrical Muscle Stimulation on Upper and Lower Limb Muscles in Critically Ill Patients: A Two-Center Randomized Controlled Trial"	"No reply"
"NEED 2022"	"None"	"Management"	"Not drug trial"	90	"(40,100]"	2772	"(2000,5000]"	"No"	"3/2018-7/2019"	"2018-03-01"	"2019-07-01"	1.3333333333333333	"Crit Care"	2022	"10.1186/s13054-022-03921-5"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Actively implementing an evidence-based feeding guideline for critically ill patients (NEED): a multicenter, cluster-randomized, controlled trial"	"No reply"
"Nguyen 2018"	"None"	"Drug"	"2"	5	"(1,5]"	19	"(0,100]"	"No"	"7/2010-6/2012"	"2010-07-01"	"2012-06-01"	1.918032786885246	"Crit Care"	2018	"10.1186/s13054-018-2124-8"	"No"	"Yes"	"No"	"Unspecified"	"Unspecified"	"Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial"	"No reply"
"Nishikimi 2018"	"None"	"Drug"	"3"	1	"(0,1]"	92	"(0,100]"	"No"	"5/2015-4/2017"	"2015-05-01"	"2017-04-01"	1.9178082191780823	"Crit Care Med"	2018	"10.1097/CCM.0000000000003132"	"No"	"Yes"	"No"	"Slow enrollment"	"Slow enrolment"	"Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial"	"No reply"
"ObiWEAN 2021"	"None"	"Device"	"Not drug trial"	1	"(0,1]"	106	"(100,250]"	"No"	"10/2018-7/2020"	"2018-10-01"	"2020-07-01"	1.748633879781421	"Intensive Care Med"	2021	"10.1007/s00134-021-06450-x"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"High-flow oxygen during spontaneous breathing trial for patients at high risk of weaning failure"	"No reply"
"ORANGES 2020"	"https://clinicaltrials.gov/ct2/show/NCT03422159"	"Drug"	"2"	2	"(1,5]"	140	"(100,250]"	"No"	"2/2018-6/2019"	"2018-02-01"	"2019-06-01"	1.3287671232876712	"Chest"	2020	"10.1016/j.chest.2020.02.049"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis The ORANGES Trial"	"No reply"
"ORI2 2019"	"None"	"Management"	"Not drug trial"	1	"(0,1]"	150	"(100,250]"	"No"	"4/2017-4/2018"	"2017-04-01"	"2018-04-01"	1	"Intensive Care Med"	2019	"10.1007/s00134-019-05732-9"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"ORI monitoring allows a reduction of time with hyperoxia in critically ill patients: the randomized control ORI2 study"	"No reply"
"Paonessa 2019"	"https://clinicaltrials.gov/ct2/show/NCT02660554"	"Management"	"Not drug trial"	1	"(0,1]"	45	"(0,100]"	"No"	"5/2016-1/2017"	"2016-05-01"	"2017-01-01"	0.6712328767123288	"Chest"	2019	"10.1016/j.chest.2019.02.007"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Rapid Detection of Methicillin-Resistant Staphylococcus aureus in BAL A Pilot Randomized Controlled Trial"	"Not used"
"Pascale 2020"	"https://clinicaltrials.gov/ct2/show/NCT03117439"	"Management"	"Not drug trial"	1	"(0,1]"	120	"(100,250]"	"No"	"7/2016-6/2018"	"2016-07-01"	"2018-06-01"	1.9178082191780823	"Crit Care"	2020	"10.1186/s13054-020-03265-y"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"(1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial"	"No reply"
"Patel 2016"	"None"	"Device"	"Not drug trial"	1	"(0,1]"	83	"(0,100]"	"No"	"10/2012-9/2015"	"2012-10-01"	"2015-09-01"	2.9178082191780823	"JAMA"	2016	"10.1001/jama.2016.6338"	"No"	"Yes"	"Yes"	"Superiority"	"Efficacy/superiority"	"Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome A Randomized Clinical Trial"	"No reply"
"PHARLAP 2019"	"https://clinicaltrials.gov/ct2/show/NCT01667146"	"Management"	"Not drug trial"	35	"(20,40]"	115	"(100,250]"	"No"	"10/2012-10/2017"	"2012-10-01"	"2017-10-01"	5	"Am J Respir Crit Care Med"	2019	"10.1164/rccm.201901-0109OC"	"No"	"Yes"	"No"	"Safety concerns and perceived loss of equipoise (due to ART trial being published) + slow recruitment"	"Safety + loss of equipoise"	"Maximal Recruitment Open Lung Ventilation in Acute Respiratory Distress Syndrome (PHARLAP) -  A Phase II, Multicenter Randomized Controlled Clinical Trial"	"No reply"
"PLUS 2022"	"https://clinicaltrials.gov/ct2/show/NCT02721654"	"Drug"	"4"	53	"(40,100]"	5037	"(5000,26982]"	"No"	"9/2017-12/2020"	"2017-09-01"	"2020-12-01"	3.249315068493151	"NEJM"	2022	"10.1056/NEJMoa2114464"	"No"	"Yes"	"No"	"Uncertainty over future recruitment and funding due to COVID19 pandemic"	"COVID-19"	"Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults"	"Not used"
"Postle 2022"	"None"	"Device"	"Not drug trial"	1	"(0,1]"	10	"(0,100]"	"Yes"	"6/2020-11/2022"	"2020-06-01"	"2022-11-01"	2.419178082191781	"Am J Respir Crit Care Med"	2021	"10.1164/rccm.202110-2279LE"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Rapid Phospholipid Turnover after Surfactant Nebulization in Severe COVID-19 Infection: A Randomized Clinical Trial"	"No reply"
"PREVAIL 2016"	"None"	"Drug"	"2"	5	"(1,5]"	214	"(100,250]"	"No"	"11/2013-9/2016"	"2013-11-01"	"2016-09-01"	2.8333333333333335	"Crit Care Med"	2018	"10.1097/CCM.0000000000003294"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Prevention of Nosocomial Infections in Critically Ill  Patients With Lactoferrin: A Randomized,  Double-Blind, Placebo-Controlled Study"	"Not used"
"PreVent 2019"	"https://clinicaltrials.gov/ct2/show/NCT03026322"	"Device"	"Not drug trial"	7	"(5,10]"	401	"(250,500]"	"No"	"3/2017-5/2018"	"2017-03-01"	"2018-05-01"	1.167123287671233	"NEJM"	2019	"10.1056/NEJMoa1812405"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Bag-Mask Ventilation during Tracheal Intubation of Critically Ill Adults"	"Not used"
"PREVENT 2019"	"https://clinicaltrials.gov/ct2/show/NCT02040103, https://www.isrctn.com/ISRCTN44653506"	"Device"	"Not drug trial"	20	"(10,20]"	2003	"(2000,5000]"	"No"	"7/2014-8/2018"	"2014-07-01"	"2018-08-01"	4.0849315068493155	"NEJM"	2019	"10.1056/NEJMoa1816150"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis"	"No reply"
"PROGRESS 2021"	"https://clinicaltrials.gov/ct2/show/NCT03333304"	"Management"	"Not drug trial"	7	"(5,10]"	266	"(250,500]"	"No"	"11/2017-1/2019"	"2017-11-01"	"2019-01-01"	1.167123287671233	"Am J Respir Crit Care Med"	2021	"10.1164/rccm.202004-1201OC"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis A Randomized Trial"	"No reply"
"PROPEL 2020"	"None"	"Device"	"Not drug trial"	12	"(10,20]"	159	"(100,250]"	"No"	"2/2016-2/2018"	"2016-02-01"	"2018-02-01"	2	"Crit Care Med"	2020	"10.1097/CCM.0000000000004176"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Promotion of Regular Oesophageal Motility to Prevent Regurgitation and Enhance Nutrition Intake in Long-Stay ICU Patients. A Multicenter, Phase II, Sham-Controlled, Randomized Trial: The PROPEL Study"	"No reply to clarification"
"PROSPECT-FULL 2021"	"https://clinicaltrials.gov/ct2/show/NCT02462590"	"Drug"	"4"	44	"(40,100]"	2653	"(2000,5000]"	"No"	"10/2013-3/2019"	"2013-10-01"	"2019-03-01"	5.413698630136986	"JAMA"	2021	"10.1001/jama.2021.13355"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients"	"No reply"
"PROTECTION 2021"	"https://clinicaltrials.gov/ct2/show/NCT03201263"	"Management"	"Not drug trial"	20	"(10,20]"	258	"(250,500]"	"No"	"12/2017-5/2019"	"2017-12-01"	"2019-05-01"	1.4136986301369863	"Chest"	2021	"10.1016/j.chest.2020.10.079"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Sigh in Patients With Acute Hypoxemic Respiratory Failure and ARDS The PROTECTION Pilot Randomized Clinical Trial"	"Not used"
"PROTRACH 2019"	"https://clinicaltrials.gov/ct2/show/NCT02700321"	"Management"	"Not drug trial"	7	"(5,10]"	192	"(100,250]"	"No"	"4/2016-6/2017"	"2016-04-01"	"2017-06-01"	1.167123287671233	"Intensive Care Med"	2019	"10.1007/s00134-019-05529-w"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Nasal high-flow preoxygenation for endotracheal intubation in the critically ill patient: a randomized clinical trial"	"No reply"
"RADAR-2 2022"	"None"	"Management"	"Not drug trial"	8	"(5,10]"	180	"(100,250]"	"No"	"4/2018-1/2020"	"2018-04-01"	"2020-01-01"	1.751366120218579	"Intensive Care Med"	2022	"10.1007/s00134-021-06596-8"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial"	"Not used"
"REACTOR 2019"	"None"	"Management"	"Not drug trial"	9	"(5,10]"	184	"(100,250]"	"No"	"11/2016-3/2019"	"2016-11-01"	"2019-03-01"	2.328767123287671	"Intensive Care Med"	2019	"10.1007/s00134-019-05729-4"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Randomised evaluation of active control of temperature versus ordinary temperature management (REACTOR) trial"	"Not used"
"REDOXS 2013"	"None"	"Drug"	"3"	40	"(20,40]"	1223	"(1000,2000]"	"No"	"4/2005-12/2011"	"2005-04-01"	"2011-12-01"	6.666666666666667	"NEJM"	2013	"10.1056/NEJMoa1212722"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients"	"No reply to clarification"
"REDUCE 2018"	"https://clinicaltrials.gov/ct2/show/NCT01785290, https://clinicaltrials.gov/ct2/show/NCT01785290"	"Drug"	"4"	21	"(20,40]"	1796	"(1000,2000]"	"No"	"7/2013-12/2016"	"2013-07-01"	"2016-12-01"	3.419178082191781	"JAMA"	2018	"10.1001/jama.2018.0160"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium The REDUCE Randomized Clinical Trial"	"Not used"
"RELAx 2020"	"https://clinicaltrials.gov/ct2/show/NCT03167580"	"Management"	"Not drug trial"	8	"(5,10]"	980	"(500,1000]"	"No"	"10/2017-12/2019"	"2017-10-01"	"2019-12-01"	2.1666666666666665	"JAMA"	2020	"10.1001/jama.2020.23517"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of a Lower vs Higher Positive End-Expiratory Pressure Strategy on Ventilator-Free Days in ICU Patients Without ARDS: A Randomized Clinical Trial"	"No reply"
"RELEASE 2019"	"https://clinicaltrials.gov/ct2/show/NCT02001220, https://clinicaltrials.gov/ct2/show/NCT02243449"	"Management"	"Not drug trial"	10	"(5,10]"	59	"(0,100]"	"No"	"1/2015-9/2015"	"2015-01-01"	"2015-09-01"	0.6657534246575343	"Crit Care Med"	2019	"10.1097/CCM.0000000000003722"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Frequency of Screening for Weaning From Mechanical Ventilation: Two Contemporaneous Proof-of-Principle Randomized Controlled Trials [RELEASE]"	"Not used"
"REMAP-CAP, ACTIV-4a, ATTACC (anticoagulation) 2021"	"https://clinicaltrials.gov/ct2/show/NCT02735707, https://clinicaltrials.gov/ct2/show/NCT04505774, https://clinicaltrials.gov/ct2/show/NCT04359277, https://clinicaltrials.gov/ct2/show/NCT04372589"	"Drug"	"2+3"	393	"(100,393]"	1207	"(1000,2000]"	"Yes"	"4/2020-12/2020"	"2020-04-01"	"2020-12-01"	0.6684931506849315	"NEJM"	2021	"10.1056/NEJMoa2103417"	"Yes"	"Yes"	"Yes"	"Futility (but adaptive stopping)"	"Futility"	"Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19"	"Not used"
"REMAP-CAP (antiplatelet domain) 2022"	"https://clinicaltrials.gov/ct2/show/NCT02735707"	"Drug"	"3"	105	"(100,393]"	1842	"(1000,2000]"	"Yes"	"10/2020-6/2021"	"2020-10-01"	"2021-06-01"	0.6657534246575343	"JAMA"	2022	"10.1001/jama.2022.2910"	"Yes"	"Yes"	"Yes"	"Futility (but adaptive stopping)"	"Futility"	"Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial"	"No reply"
"REMAP-CAP (antiviral domain) 2021"	"https://clinicaltrials.gov/ct2/show/NCT02735707"	"Drug"	"3"	99	"(40,100]"	694	"(500,1000]"	"Yes"	"4/2020-11/2020"	"2020-04-01"	"2020-11-01"	0.5863013698630137	"Intensive Care Med"	2021	"10.1007/s00134-021-06448-5"	"No"	"Yes"	"Yes"	"Futility (but adaptive stopping)"	"Futility"	"Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial"	"No reply"
"REMAP-CAP (IL-6 domain) 2021"	"https://clinicaltrials.gov/ct2/show/NCT02735707"	"Drug"	"3"	113	"(100,393]"	826	"(500,1000]"	"Yes"	"4/2020-11/2020"	"2020-04-01"	"2020-11-01"	0.5863013698630137	"NEJM"	2021	"10.1056/NEJMoa2100433"	"Yes"	"Yes"	"Yes"	"Efficacy (but adaptive stopping)"	"Efficacy/superiority"	"Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19"	"Not used"
"REMAP-CAP (immunoglobulin domain) 2021"	"https://clinicaltrials.gov/ct2/show/NCT02735707"	"Drug"	"3"	129	"(100,393]"	2097	"(2000,5000]"	"Yes"	"3/2020-1/2021"	"2020-03-01"	"2021-01-01"	0.8383561643835616	"JAMA"	2021	"10.1001/jama.2021.18178"	"No"	"Yes"	"Yes"	"Futility"	"Futility"	"Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial"	"No reply"
"REMAP-CAP (steroid domain) 2020"	"https://clinicaltrials.gov/ct2/show/NCT02735707"	"Drug"	"3"	113	"(100,393]"	403	"(250,500]"	"Yes"	"3/2020-6/2020"	"2020-03-01"	"2020-06-01"	0.25205479452054796	"JAMA"	2020	"10.1001/jama.2020.17022"	"Yes"	"Yes"	"No"	"Loss of equipoise (RECOVERY trial published)"	"Loss of equipoise"	"Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial"	"Not used"
"RESCUE-2 2022"	"https://clinicaltrials.gov/ct2/show/NCT03096639"	"Device"	"Not drug trial"	20	"(10,20]"	112	"(100,250]"	"No"	"9/2017-1/2020"	"2017-09-01"	"2020-01-01"	2.3333333333333335	"Am J Respir Crit Care Med"	2022	"10.1164/rccm.202107-1709OC"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Randomized Clinical Study of Temporary Transvenous Phrenic Nerve Stimulation in Difficult-to-Wean Patients"	"No reply"
"REST 2021"	"https://clinicaltrials.gov/ct2/show/NCT02654327"	"Device"	"Not drug trial"	51	"(40,100]"	412	"(250,500]"	"No"	"5/2016-12/2019"	"2016-05-01"	"2019-12-01"	3.5846994535519126	"JAMA"	2021	"10.1001/jama.2021.13374"	"No"	"Yes"	"No"	"Futility (although no formal stopping rule) and feasibility"	"Futility"	"Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure"	"No reply"
"REVERSE-AKI 2021"	"None"	"Management"	"Not drug trial"	7	"(5,10]"	100	"(0,100]"	"No"	"10/2017-1/2020"	"2017-10-01"	"2020-01-01"	2.251366120218579	"Intensive Care Med"	2021	"10.1007/s00134-021-06401-6"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Restrictive fluid management versus usual
care in acute kidney injury (REVERSE-AKI): a pilot
randomized controlled feasibility trial"	"No reply"
"RICH 2020"	"https://clinicaltrials.gov/ct2/show/NCT02669589"	"Drug"	"4"	26	"(20,40]"	638	"(500,1000]"	"No"	"3/2016-12/2018"	"2016-03-01"	"2018-12-01"	2.7534246575342465	"JAMA"	2020	"10.1001/jama.2020.18618"	"No"	"No"	"Yes"	"Not stopped"	"Not stopped"	"Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial"	"No reply"
"Ridley 2018"	"https://clinicaltrials.gov/ct2/show/NCT01847534"	"Drug"	"2"	6	"(5,10]"	100	"(0,100]"	"No"	"2/2014-1/2016"	"2014-02-01"	"2016-01-01"	1.915068493150685	"Crit Care"	2018	"10.1186/s13054-018-1939-7"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Supplemental parenteral nutrition versus usual care in critically ill adults: a pilot randomized controlled study"	"No reply"
"RIFTS 2019"	"None"	"Drug"	"4"	2	"(1,5]"	113	"(100,250]"	"No"	"11/2016-2/2018"	"2016-11-01"	"2018-02-01"	1.252054794520548	"Crit Care Med"	2019	"10.1097/CCM.0000000000003779"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"The Restrictive IV Fluid Trial in Severe Sepsis and Septic Shock (RIFTS): A Randomized Pilot Study"	"No reply"
"ROSE 2019"	"https://clinicaltrials.gov/ct2/show/NCT02509078"	"Drug"	"3"	48	"(40,100]"	1008	"(1000,2000]"	"No"	"1/2016-4/2018"	"2016-01-01"	"2018-04-01"	2.2465753424657535	"NEJM"	2019	"10.1056/NEJMoa1901686"	"No"	"Yes"	"Yes"	"Futility"	"Futility"	"Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome"	"Not used"
"Rosengrave 2022"	"None"	"Drug"	"1+2"	1	"(0,1]"	40	"(0,100]"	"No"	"5/2018-6/2020"	"2018-05-01"	"2020-06-01"	2.084931506849315	"Crit Care"	2022	"10.1186/s13054-022-03900-w"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Intravenous vitamin C administration to patients with septic shock: a pilot randomised controlled trial"	"Replied, without answer to the question"
"Rosetti 2020"	"None"	"Device"	"Not drug trial"	3	"(1,5]"	402	"(250,500]"	"No"	"4/2017-11/2018"	"2017-04-01"	"2018-11-01"	1.5863013698630137	"JAMA Neurol"	2020	"10.1001/jamaneurol.2020.2264"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Continuous vs Routine Electroencephalogram in Critically Ill Adults With Altered Consciousness and No Recent Seizure: A Multicenter Randomized Clinical Trial"	"Not used"
"Rozencwajg 2019"	"None"	"Management"	"Not drug trial"	1	"(0,1]"	16	"(0,100]"	"No"	"1/2017-9/2017"	"2017-01-01"	"2017-09-01"	0.6657534246575343	"Crit Care Med"	2019	"10.1097/CCM.0000000000003894"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Ultra-Protective Ventilation Reduces Biotrauma in Patients on Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome"	"No reply"
"RSVP 2020"	"None"	"Management"	"Not drug trial"	10	"(5,10]"	2944	"(2000,5000]"	"No"	"5/2011-12/2016"	"2011-05-01"	"2016-12-01"	5.586301369863014	"Lancet"	2021	"10.1016/S0140-6736(21)00351-2"	"No"	"Yes"	"N/A"	"Slow recruitment to one of the arms"	"Slow enrolment"	"Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device), non-inferiority (peripheral arterial catheter) trial"	"Not used"
"SALT 2017"	"None"	"Drug"	"4"	1	"(0,1]"	974	"(500,1000]"	"No"	"2/2015-5/2015"	"2015-02-01"	"2015-05-01"	0.24383561643835616	"Am J Respir Crit Care Med"	2017	"10.1164/rccm.201607-1345OC"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Balanced Crystalloids versus Saline in the Intensive Care Unit The SALT Randomized Trial"	"Not used"
"Sedaconda 2021"	"None"	"Drug"	"3"	24	"(20,40]"	301	"(250,500]"	"No"	"7/2017-1/2020"	"2017-07-01"	"2020-01-01"	2.5027322404371586	"Lancet Respir Med"	2021	"10.1016/S2213-2600(21)00323-4"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase 3, randomised controlled, non-inferiority trial"	"No reply"
"SedaEN 2019"	"https://clinicaltrials.gov/ct2/show/NCT01360346"	"Drug"	"3"	12	"(10,20]"	348	"(250,500]"	"No"	"1/2012-12/2012"	"2012-01-01"	"2012-12-01"	0.9153005464480874	"Crit Care"	2019	"10.1186/s13054-018-2280-x"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Enteral versus intravenous approach for the sedation of critically ill patients: a randomized and controlled trial"	"No reply"
"Sehgal 2021"	"https://clinicaltrials.gov/ct2/show/NCT02330432"	"Drug"	"2b"	5	"(1,5]"	202	"(100,250]"	"No"	"1/2016-10/2018"	"2016-01-01"	"2018-10-01"	2.747945205479452	"Chest"	2021	"10.1016/j.chest.2021.03.062"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"A Randomized Trial of Mycobacterium w in Severe Presumed Gram-Negative Sepsis"	"No reply"
"SENIOR 2019"	"https://clinicaltrials.gov/ct2/show/NCT02001220, https://clinicaltrials.gov/ct2/show/NCT02243449"	"Management"	"Not drug trial"	11	"(10,20]"	107	"(100,250]"	"No"	"1/2015-12/2015"	"2015-01-01"	"2015-12-01"	0.915068493150685	"Crit Care Med"	2019	"10.1097/CCM.0000000000003722"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Frequency of Screening for Weaning From Mechanical Ventilation: Two Contemporaneous Proof-of-Principle Randomized Controlled Trials"	"Not used"
"SETPOINT2 2022"	"https://clinicaltrials.gov/ct2/show/NCT02377167"	"Management"	"Not drug trial"	26	"(20,40]"	382	"(250,500]"	"No"	"7/2015-1/2020"	"2015-07-01"	"2020-01-01"	4.502732240437158	"JAMA"	2022	"10.1001/jama.2022.4798"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Early vs Standard Approach to Tracheostomy on Functional Outcome at 6 Months Among Patients With Severe Stroke Receiving Mechanical Ventilation The SETPOINT2 Randomized Clinical Trial"	"Not used"
"Shimizu 2018"	"None"	"Drug"	"3"	1	"(0,1]"	77	"(0,100]"	"No"	"11/2011-9/2016"	"2011-11-01"	"2016-09-01"	4.833333333333333	"Crit Care"	2018	"10.1186/s13054-018-2167-x"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial"	"No reply"
"Song 2019"	"ChiCTR/ChiCTR-TRC-13003534"	"Drug"	"4"	33	"(20,40]"	710	"(500,1000]"	"No"	"9/2013-12/2015"	"2013-09-01"	"2015-12-01"	2.248633879781421	"Crit Care Med"	2019	"10.1097/CCM.0000000000003842"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial"	"No reply"
"SPICE III 2019"	"https://clinicaltrials.gov/ct2/show/NCT01728558"	"Drug"	"3"	74	"(40,100]"	4000	"(2000,5000]"	"No"	"11/2013-2/2018"	"2013-11-01"	"2018-02-01"	4.252054794520548	"NEJM"	2019	"10.1056/NEJMoa1904710"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Early Sedation with Dexmedetomidine in Critically Ill Patients"	"No reply"
"STAR 2021"	"https://clinicaltrials.gov/ct2/show/NCT02326350"	"Drug"	"2"	5	"(1,5]"	49	"(0,100]"	"No"	"2/2015-11/2018"	"2015-02-01"	"2018-11-01"	3.747945205479452	"Chest"	2022	"10.1016/j.chest.2021.11.006"	"No"	"Yes"	"No"	"Slow recruitment"	"Slow enrolment"	"Aspirin as a Treatment for ARDS A Randomized, Placebo-Controlled Clinical Trial"	"No reply"
"START 2019"	"https://clinicaltrials.gov/ct2/show/NCT02097641"	"Drug"	"2a"	5	"(1,5]"	63	"(0,100]"	"No"	"3/2014-2/2017"	"2014-03-01"	"2017-02-01"	2.9232876712328766	"Lancet Respir Med"	2019	"10.1016/S2213-2600(18)30418-1"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial"	"No reply"
"STYLETO 2021"	"None"	"Device"	"Not drug trial"	32	"(20,40]"	1040	"(1000,2000]"	"No"	"10/2019-3/2020"	"2019-10-01"	"2020-03-01"	0.41530054644808745	"Intensive Care Med"	2021	"10.1007/s00134-021-06417-y"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of the use of an endotracheal tube and stylet versus an endotracheal tube alone on first-attempt intubation success: a multicentre, randomised clinical trial in 999 patients"	"No reply"
"Supinski 2021"	"https://clinicaltrials.gov/ct2/show/NCT01270516"	"Drug"	"3"	1	"(0,1]"	73	"(0,100]"	"No"	"1/2014-1/2020"	"2014-01-01"	"2020-01-01"	6	"Crit Care"	2021	"10.1186/s13054-021-03737-9"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"A randomized controlled trial to determine whether beta-hydroxy-beta-methylbutyrate and/or eicosapentaenoic acid improves diaphragm and quadriceps strength in critically Ill mechanically ventilated patients"	"No reply"
"SWIPE 2018"	"None"	"Drug"	"4"	3	"(1,5]"	330	"(250,500]"	"No"	"7/2015-2/2017"	"2015-07-01"	"2017-02-01"	1.589041095890411	"Intensive Care Med"	2018	"10.1007/s00134-018-5253-2"	"No"	"Yes"	"No"	"Adequat separation (feasibility)"	"Feasibility shown"	"Small volume resuscitation with 20% albumin in intensive care: physiological effects"	"Not used"
"Tan 2020"	"None"	"Management"	"Not drug trial"	2	"(1,5]"	96	"(0,100]"	"No"	"1/2019-2/2020"	"2019-01-01"	"2020-02-01"	1.0846994535519126	"Crit Care"	2020	"10.1186/s13054-020-03214-9"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial"	"No reply"
"TARGET 2022"	"None"	"Management"	"Not drug trial"	13	"(10,20]"	254	"(250,500]"	"No"	"1/2017-12/2019"	"2017-01-01"	"2019-12-01"	2.915068493150685	"Intensive Care Med"	2022	"10.1007/s00134-021-06609-6"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial"	"No reply"
"Tholen 2021"	"https://clinicaltrials.gov/ct2/show/NCT02531724"	"Drug"	"4"	1	"(0,1]"	29	"(0,100]"	"No"	"9/2015-6/2020"	"2015-09-01"	"2020-06-01"	4.748633879781421	"Crit Care"	2021	"10.1186/s13054-021-03628-z"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effects of levosimendan on renal blood flow and glomerular filtration in patients with acute kidney injury after cardiac surgery: a double blind, randomized placebo-controlled study"	"Not used"
"TOPMAST 2019"	"None"	"Drug"	"4"	1	"(0,1]"	70	"(0,100]"	"No"	"3/2017-7/2018"	"2017-03-01"	"2018-07-01"	1.3342465753424657	"Intensive Care Med"	2019	"10.1007/s00134-019-05772-1"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"154 compared to 54 mmol per liter of sodium in intravenous maintenance fluid therapy for adult patients undergoing major thoracic surgery (TOPMAST): a single-center  randomized controlled double-blind trial"	"No reply"
"TTM2 2021"	"https://clinicaltrials.gov/ct2/show/NCT02908308"	"Management"	"Not drug trial"	61	"(40,100]"	1900	"(1000,2000]"	"No"	"11/2017-1/2020"	"2017-11-01"	"2020-01-01"	2.1666666666666665	"NEJM"	2021	"10.1056/NEJMoa2100591"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest"	"Not used"
"UNDERPIN-ICU 2021"	"https://clinicaltrials.gov/ct2/show/NCT03002701"	"Management"	"Not drug trial"	10	"(5,10]"	1749	"(1000,2000]"	"No"	"12/2016-5/2019"	"2016-12-01"	"2019-05-01"	2.4136986301369863	"Am J Respir Crit Care Med"	2021	"10.1164/rccm.202101-0082OC"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"The Impact of Nursing Delirium Preventive Interventions in the ICU A Multicenter Cluster-randomized Controlled Clinical Trial"	"Not used"
"VA/NIH 2008"	"https://clinicaltrials.gov/ct2/show/NCT00076219"	"Management"	"Not drug trial"	27	"(20,40]"	1124	"(1000,2000]"	"No"	"11/2003-7/2007"	"2003-11-01"	"2007-07-01"	3.663013698630137	"NEJM"	2008	"10.1056/NEJMoa0802639"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury"	"Not used"
"VANISH 2016"	"None"	"Drug"	"4"	18	"(10,20]"	421	"(250,500]"	"No"	"2/2013-5/2015"	"2013-02-01"	"2015-05-01"	2.243835616438356	"JAMA"	2016	"10.1001/jama.2016.10485"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock The VANISH Randomized Clinical Trial"	"Not used"
"van Meenen 2018"	"https://clinicaltrials.gov/ct2/show/NCT02159196"	"Drug"	"4"	7	"(5,10]"	944	"(500,1000]"	"No"	"6/2014-11/2016"	"2014-06-01"	"2016-11-01"	2.419178082191781	"JAMA"	2018	"10.1001/jama.2018.0949"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of On-Demand vs Routine Nebulization of Acetylcysteine With Salbutamol on Ventilator-Free Days in Intensive Care Unit Patients Receiving Invasive Ventilation A Randomized Clinical Trial"	"No reply"
"vanZanten 2018"	"None"	"Drug"	"3"	4	"(1,5]"	44	"(0,100]"	"No"	"3/2016-2/2017"	"2016-03-01"	"2017-02-01"	0.9232876712328767	"Crit Care"	2018	"10.1186/s13054-018-2070-5"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Very high intact-protein formula successfully provides protein intake according to nutritional recommendations in overweight critically ill patients: a double-blind randomized trial"	"Not used"
"VAPrapid2 2020"	"https://clinicaltrials.gov/ct2/show/NCT01972425, https://www.isrctn.com/ISRCTN65937227"	"Management"	"Not drug trial"	24	"(20,40]"	210	"(100,250]"	"No"	"11/2013-9/2016"	"2013-11-01"	"2016-09-01"	2.8333333333333335	"Lancet Respir Med"	2020	"10.1016/S2213-2600(19)30367-4"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation"	"No reply"
"Vaschetto 2019"	"None"	"Management"	"Not drug trial"	9	"(5,10]"	130	"(100,250]"	"No"	"10/2013-10/2016"	"2013-10-01"	"2016-10-01"	3	"Intensive Care Med"	2019	"10.1007/s00134-018-5478-0"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Early extubation followed by immediate noninvasive ventilation vs. standard extubation in hypoxemic patients: a randomized clinical trial"	"No reply"
"Villar 2020"	"https://clinicaltrials.gov/ct2/show/NCT01731795"	"Drug"	"4"	17	"(10,20]"	277	"(250,500]"	"No"	"3/2013-12/2018"	"2013-03-01"	"2018-12-01"	5.7534246575342465	"Lancet Respir Med"	2020	"10.1016/ S2213-2600(19)30417-5"	"Yes"	"Yes"	"No"	"Slow enrolment"	"Slow enrolment"	"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial"	"No reply"
"VIOLET 2019"	"https://clinicaltrials.gov/ct2/show/NCT03096314"	"Drug"	"3"	44	"(40,100]"	1360	"(1000,2000]"	"No"	"4/2017-7/2018"	"2017-04-01"	"2018-07-01"	1.2493150684931507	"NEJM"	2019	"10.1056/NEJMoa1911124"	"No"	"Yes"	"Yes"	"Futility"	"Futility"	"Early High-Dose Vitamin D3  for Critically Ill, Vitamin D–Deficient Patients"	"Not used"
"VivaITN 2018"	"https://clinicaltrials.gov/ct2/show/NCT02837055"	"Device"	"Not drug trial"	1	"(0,1]"	54	"(0,100]"	"No"	"6/2016-1/2018"	"2016-06-01"	"2018-01-01"	1.5863013698630137	"Crit Care"	2018	"10.1186/s13054-018-2152-4"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Endotracheal tube-mounted camera- assisted intubation versus conventional intubation in intensive care: a prospective, randomised trial (VivaITN)"	"Not used"
"Wacker 2022"	"https://clinicaltrials.gov/ct2/show/NCT03338569"	"Drug"	"2+3"	5	"(1,5]"	125	"(100,250]"	"No"	"1/2018-6/2020"	"2018-01-01"	"2020-06-01"	2.4153005464480874	"Crit Care Med"	2022	"10.1097/CCM.0000000000005427"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Evaluating Vitamin C in Septic Shock: A Randomized Controlled Trial of Vitamin C Monotherapy"	"No reply to clarification"
"Wang 2020"	"None"	"Management"	"Not drug trial"	1	"(0,1]"	104	"(100,250]"	"No"	"5/2015-4/2019"	"2015-05-01"	"2019-04-01"	3.9178082191780823	"Crit Care Med"	2020	"10.1097/CCM.0000000000004445"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Mechanical Ventilation Strategy Guided by Transpulmonary Pressure in Severe Acute Respiratory Distress Syndrome Treated With Venovenous Extracorporeal Membrane Oxygenation"	"No reply"
"Weidhase 2020"	"https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00012407"	"Device"	"Not drug trial"	1	"(0,1]"	70	"(0,100]"	"No"	"5/2017-9/2018"	"2017-05-01"	"2018-09-01"	1.336986301369863	"Crit Care"	2020	"10.1186/s13054-020-03366-8"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial"	"No reply to clarification"
"Wiberg 2016"	"https://clinicaltrials.gov/ct2/show/NCT02442791"	"Drug"	"3"	2	"(1,5]"	120	"(100,250]"	"No"	"6/2014-11/2015"	"2014-06-01"	"2015-11-01"	1.418032786885246	"Circulation"	2016	"10.1161/CIRCULATIONAHA.116.024088"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest A Randomized Controlled Trial"	"Not used"
"Wittekamp 2018"	"https://clinicaltrials.gov/ct2/show/NCT02208154"	"Drug"	"3"	13	"(10,20]"	8665	"(5000,26982]"	"No"	"12/2013-5/2017"	"2013-12-01"	"2017-05-01"	3.4136986301369863	"JAMA"	2018	"10.1001/jama.2018.13765"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients A Randomized Clinical Trial"	"No reply"
"You 2018"	"None"	"Management"	"Not drug trial"	1	"(0,1]"	82	"(0,100]"	"No"	"3/2014-10/2017"	"2014-03-01"	"2017-10-01"	3.5863013698630137	"Crit Care"	2018	"10.1186/s13054-018-2095-9"	"Yes"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Early application of continuous high-volume haemofiltration can reduce sepsis and improve the prognosis of patients with severe burns"	"No reply"
"Zhou 2022"	"https://clinicaltrials.gov/ct2/show/NCT02528513"	"Drug"	"4"	1	"(0,1]"	252	"(250,500]"	"No"	"12/2015-6/2018"	"2015-12-01"	"2018-06-01"	2.4986301369863013	"Crit Care"	2022	"10.1186/s13054-022-03967-5"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Sequential use of midazolam  and dexmedetomidine for long-term sedation  may reduce weaning time in selected  critically ill, mechanically ventilated patients:  a randomized controlled study"	"No reply"
"Zhu 2018"	"None"	"Device"	"Not drug trial"	1	"(0,1]"	141	"(100,250]"	"No"	"4/2015-6/2017"	"2015-04-01"	"2017-06-01"	2.1671232876712327	"Crit Care"	2018	"10.1186/s13054-018-2092-z"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Gastric versus postpyloric enteral nutrition in elderly patients (age ≥ 75 years) on mechanical ventilation: a single-center randomized trial"	"No reply"
"BOX blood pressure 2022"	"https://clinicaltrials.gov/ct2/show/NCT03141099"	"Management"	"Not drug trial"	2	"(1,5]"	802	"(500,1000]"	"No"	"3/2017-12/2021"	"2017-03-01"	"2021-12-01"	4.7534246575342465	"NEJM"	2022	"10.1056/NEJMoa2208687"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Blood-Pressure Targets in Comatose Survivors of Cardiac Arrest"	"Not used"
"RUXCOVID-DEVENT 2022"	"https://clinicaltrials.gov/ct2/show/NCT04377620"	"Drug"	"3"	33	"(20,40]"	211	"(100,250]"	"Yes"	"5/2020-12/2020"	"2020-05-01"	"2020-12-01"	0.5863013698630137	"Crit Care Med"	2022	"10.1097/CCM.0000000000005682"	NA	"Yes"	"No"	"Slow enrolment, loss of equipoise (negative preliminary results from another trial), approval of competitor with same indication"	"Loss of equipoise"	"Randomized Phase 3 Trial of Ruxolitinib for COVID-19–Associated Acute Respiratory Distress Syndrome"	"No reply"
"NICOVID-REA 2022"	"https://clinicaltrials.gov/ct2/show/NCT04598594"	"Drug"	"3"	18	"(10,20]"	220	"(100,250]"	"Yes"	"11/2020-4/2021"	"2020-11-01"	"2021-04-01"	0.4136986301369863	"Intensive Care Med"	2022	"10.1007/s00134-022-06721-1"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial"	"No reply"
"Patel 2023"	"https://clinicaltrials.gov/ct2/show/NCT01777035"	"Management"	"Not drug trial"	1	"(0,1]"	200	"(100,250]"	"No"	"8/2011-10/2019"	"2011-08-01"	"2019-10-01"	8.166666666666666	"Lancet Respir Med"	2023	"10.1016/S2213-2600(22)00489-1"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of early mobilisation on long-term cognitive impairment in critical illness in the USA: a randomised controlled trial"	"Not used"
"Tang 2022"	"None"	"Drug"	"2"	1	"(0,1]"	60	"(0,100]"	"No"	"5/2021-4/2022"	"2021-05-01"	"2022-04-01"	0.9178082191780822	"Crit Care"	2022	"10.1186/s13054-022-04168-w"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study"	"No reply"
"Right Dose Right Now 2022"	"None"	"Drug"	"3"	2	"(1,5]"	252	"(250,500]"	"No"	"2/2018-3/2020"	"2018-02-01"	"2020-03-01"	2.079234972677596	"Crit Care"	2022	"10.1186/s13054-022-04098-7"	NA	"Yes"	"No"	"COVID19 pandemic"	"COVID-19"	"Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock—a two-centre randomised clinical trial"	"Not used"
"AID-ICU 2022"	"https://clinicaltrials.gov/ct2/show/NCT03392376, https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003829-15/results"	"Drug"	"4"	16	"(10,20]"	1000	"(500,1000]"	"No"	"6/2018-4/2022"	"2018-06-01"	"2022-04-01"	3.8328767123287673	"NEJM"	2022	"10.1056/NEJMoa2211868"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Haloperidol for the Treatment of Delirium in ICU Patients"	"Not used"
"ERIC 2023"	"https://clinicaltrials.gov/ct2/show/NCT03671447"	"Management"	"Not drug trial"	14	"(10,20]"	1463	"(1000,2000]"	"No"	"9/2018-3/2020"	"2018-09-01"	"2020-03-01"	1.4972677595628414	"Intensive Care Med"	2023	"10.1007/s00134-022-06949-x"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effectiveness of an intensive care telehealth programme to improve process quality (ERIC): a multicentre stepped wedge cluster randomised controlled trial"	"Not used"
"EVADE 2022"	"https://clinicaltrials.gov/ct2/show/NCT02696902"	"Drug"	"2"	48	"(40,100]"	188	"(100,250]"	"No"	"4/2016-10/2019"	"2016-04-01"	"2019-10-01"	3.5	"Crit Care"	2022	"10.1186/s13054-022-04204-9"	NA	"Yes"	"No"	"Slow enrolment"	"Slow enrolment"	"Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial"	"No reply"
"TTOCOV19 2022"	"https://clinicaltrials.gov/ct2/show/NCT04412356"	"Management"	"Not drug trial"	3	"(1,5]"	150	"(100,250]"	"Yes"	"6/2020-4/2021"	"2020-06-01"	"2021-04-01"	0.8328767123287671	"Crit Care"	2022	"10.1186/s13054-022-04005-0"	"No"	"Yes"	"No"	"Futility"	"Futility"	"TTCOV19: timing of tracheotomy in SARS‑CoV‑2‑infected patients: a multicentre, single‑blinded, randomized, controlled trial"	"Not used"
"TiP-Ex 2022"	"https://clinicaltrials.gov/ct2/show/NCT04227639"	"Device"	"Not drug trial"	31	"(20,40]"	983	"(500,1000]"	"No"	"1/2020-6/2021"	"2020-01-01"	"2021-06-01"	1.4136986301369863	"NEJM"	2022	"10.1056/NEJMoa2209041"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-Piece"	"Not used"
"INCLASS 2022"	"https://clinicaltrials.gov/ct2/show/NCT03345992"	"Drug"	"3"	13	"(10,20]"	110	"(100,250]"	"No"	"12/2017-6/2019"	"2017-12-01"	"2019-06-01"	1.4986301369863013	"Crit Care"	2022	"10.1186/s13054-022-04055-4"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial"	"Not used"
"ABLE 2015"	"None"	"Management"	"Not drug trial"	64	"(40,100]"	2510	"(2000,5000]"	"No"	"3/2009-5/2014"	"2009-03-01"	"2014-05-01"	5.167123287671233	"NEJM"	2015	"10.1056/NEJMoa1500704"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Age of Transfused Blood in Critically Ill Adults"	"No reply"
"ECMO-VILI 2022"	"https://clinicaltrials.gov/ct2/show/NCT03918603"	"Management"	"Not drug trial"	2	"(1,5]"	39	"(0,100]"	"No"	"7/2019-4/2021"	"2019-07-01"	"2021-04-01"	1.7506849315068493	"Crit Care"	2022	"10.1186/s13054-022-04272-x"	NA	"Yes"	"Yes"	"Futility"	"Futility"	"Ultra-lung-protective ventilation and biotrauma in severe ARDS patients on veno-venous extracorporeal membrane oxygenation: a randomized controlled study"	"Not used"
"Czarnik 2023"	"https://clinicaltrials.gov/ct2/show/NCT02624323"	"Device"	"Not drug trial"	2	"(1,5]"	614	"(500,1000]"	"No"	"8/2016-8/2020"	"2016-08-01"	"2020-08-01"	4	"Crit Care Med"	2023	"10.1097/CCM.0000000000005740"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Ultrasound-Guided Infraclavicular Axillary Vein Versus Internal Jugular Vein Cannulation in Critically Ill Mechanically Ventilated Patients: A Randomized Trial"	"No reply"
"B12 2022"	"https://clinicaltrials.gov/ct2/show/NCT03783091"	"Drug"	"2"	1	"(0,1]"	20	"(0,100]"	"No"	"7/2019-10/2021"	"2019-07-01"	"2021-10-01"	2.252054794520548	"Chest"	2022	"10.1016/j.chest.2022.09.021"	NA	"Yes"	"No"	"Funding and COVID19 pandemic  (changed to feasibility outcome due to i.a. COVID19 so not stopped per se)"	"Funding exhausted"	"High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic Shock A Double-Blind, Allocation-Concealed, Placebo-Controlled Single-Center Pilot Randomized Controlled Trial (The Intravenous Hydroxocobalamin in Septic Shock Trial)"	"No reply"
"COVI-PRONE 2022"	"https://clinicaltrials.gov/ct2/show/NCT04350723"	"Management"	"Not drug trial"	21	"(20,40]"	400	"(250,500]"	"Yes"	"5/2020-5/2021"	"2020-05-01"	"2021-05-01"	1	"JAMA"	2022	"10.1001/jama.2022.7993"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial"	"No reply"
"Hung 2022"	"https://clinicaltrials.gov/ct2/show/NCT05295381"	"Device"	"Not drug trial"	1	"(0,1]"	40	"(0,100]"	"No"	"8/2019-8/2020"	"2019-08-01"	"2020-08-01"	1	"Crit Care"	2022	"10.1186/s13054-022-04012-1"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of abdominal weight training with and without cough machine assistance on lung function in the patients with prolonged mechanical ventilation: a randomized trial"	"No reply"
"Cuzco 2022"	"https://clinicaltrials.gov/ct2/show/NCT04527627"	"Management"	"Not drug trial"	3	"(1,5]"	178	"(100,250]"	"No"	"9/2019-4/2021"	"2019-09-01"	"2021-04-01"	1.580821917808219	"Crit Care Med"	2022	"10.1097/CCM.0000000000005676"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Impact of a Nurse-Driven Patient Empowerment Intervention on the Reduction in Patients’ Anxiety and Depression During ICU Discharge: A Randomized Clinical Trial"	"Not used"
"BOX oxygen 2022"	"https://clinicaltrials.gov/ct2/show/NCT03141099"	"Drug"	"4"	2	"(1,5]"	802	"(500,1000]"	"No"	"3/2017-12/2021"	"2017-03-01"	"2021-12-01"	4.7534246575342465	"NEJM"	2022	"10.1056/NEJMoa2208686"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Oxygen Targets in Comatose Survivors of Cardiac Arrest"	"Not used"
"RE-ENERGIZE 2022"	"https://clinicaltrials.gov/ct2/show/NCT00985205"	"Drug"	"3"	54	"(40,100]"	1209	"(1000,2000]"	"No"	"5/2011-6/2021"	"2011-05-01"	"2021-06-01"	10.084931506849315	"NEJM"	2022	"10.1056/NEJMoa2203364"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"A Randomized Trial of Enteral Glutamine for Treatment of Burn Injuries"	"No reply"
"Ke 2022"	"None"	"Drug"	"4"	16	"(10,20]"	508	"(500,1000]"	"No"	"3/2017-12/2020"	"2017-03-01"	"2020-12-01"	3.7534246575342465	"Intensive Care Med"	2022	"10.1007/s00134-022-06745-7"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Immune enhancement in patients with predicted severe acute necrotising pancreatitis: a multicentre double-blind randomised controlled trial"	"No reply"
"Bowdish 2023"	"None"	"Drug"	"3"	20	"(10,20]"	223	"(100,250]"	"Yes"	"4/2020-12/2020"	"2020-04-01"	"2020-12-01"	0.6684931506849315	"Am J Respir Crit Care Med"	2023	"10.1164/rccm.202201-0157OC"	NA	"Yes"	"Yes"	"Futility"	"Futility"	"A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19"	"No reply"
"VALSE 2023"	"https://clinicaltrials.gov/ct2/show/NCT01791868"	"Drug"	"3"	16	"(10,20]"	245	"(100,250]"	"No"	"2/2013-7/2018"	"2013-02-01"	"2018-07-01"	5.410958904109589	"Crit Care"	2023	"10.1186/s13054-022-04292-7"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Valproic acid as adjuvant treatment for convulsive status epilepticus: a randomised clinical trial"	"Not used"
"RINO 2022"	"https://clinicaltrials.gov/ct2/show/NCT02107183"	"Device"	"Not drug trial"	13	"(10,20]"	517	"(500,1000]"	"No"	"6/2014-10/2016"	"2014-06-01"	"2016-10-01"	2.334246575342466	"Am J Respir Crit Care Med"	2022	"10.1164/rccm.202201-0065OC"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"High-Flow Versus VenturiMask Oxygen Therapy to Prevent Reintubation in Hypoxemic Patients after Extubation A Multicenter Randomized Clinical Trial"	"No reply to clarification"
"RECO-Sepsis 2022"	"https://clinicaltrials.gov/ct2/show/NCT03201575"	"Management"	"Not drug trial"	6	"(5,10]"	180	"(100,250]"	"No"	"11/2017-5/2019"	"2017-11-01"	"2019-05-01"	1.4958904109589042	"Intensive Care Med"	2022	"10.1007/s00134-022-06872-1"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Remote ischemic conditioning in septic shock: the RECO-Sepsis randomized clinical trial"	"No reply"
"EFFORT Protein 2023"	"https://clinicaltrials.gov/ct2/show/NCT03160547"	"Management"	"Not drug trial"	85	"(40,100]"	1329	"(1000,2000]"	"No"	"1/2018-12/2021"	"2018-01-01"	"2021-12-01"	3.915068493150685	"Lancet"	2023	"10.1016/S0140-6736(22)02469-2"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"The effect of higher protein dosing in critically ill patients with high nutritional risk (EFFORT Protein): an international, multicentre, pragmatic, registry-based randomised trial"	"No reply"
"CandiSep 2022"	"https://clinicaltrials.gov/ct2/show/NCT02734550"	"Management"	"Not drug trial"	18	"(10,20]"	342	"(250,500]"	"No"	"9/2016-9/2019"	"2016-09-01"	"2019-09-01"	3	"Intensive Care Med"	2022	"10.1007/s00134-022-06733-x"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"(1->3)-β-d-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial"	"Not used"
"PREPARE II 2022"	"https://clinicaltrials.gov/ct2/show/NCT03787732"	"Drug"	"4"	11	"(10,20]"	1067	"(1000,2000]"	"No"	"2/2019-5/2021"	"2019-02-01"	"2021-05-01"	2.243835616438356	"JAMA"	2022	"10.1001/jama.2022.9792"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Fluid Bolus Administration on Cardiovascular Collapse Among Critically Ill Patients Undergoing Tracheal Intubation A Randomized Clinical Trial"	"Not used"
"TEAM(III) 2022"	"https://clinicaltrials.gov/ct2/show/NCT03133377"	"Management"	"Not drug trial"	49	"(40,100]"	750	"(500,1000]"	"No"	"2/2018-11/2021"	"2018-02-01"	"2021-11-01"	3.747945205479452	"NEJM"	2022	"10.1056/NEJMoa2209083"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Early Active Mobilization during Mechanical Ventilation in the ICU"	"Not used"
"SuDDICU 2022"	"https://clinicaltrials.gov/ct2/show/NCT02389036"	"Drug"	"3"	19	"(10,20]"	5982	"(5000,26982]"	"No"	"4/2018-5/2021"	"2018-04-01"	"2021-05-01"	3.0821917808219177	"JAMA"	2022	"10.1001/jama.2022.17927"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Selective Decontamination of the Digestive Tract on Hospital Mortality in Critically Ill Patients Receiving Mechanical Ventilation A Randomized Clinical Trial"	"No reply"
"EXCHANGE 2022"	"https://clinicaltrials.gov/ct2/show/NCT04231994"	"Drug"	"2"	2	"(1,5]"	40	"(0,100]"	"No"	"6/2018-7/2020"	"2018-06-01"	"2020-07-01"	2.0821917808219177	"Crit Care"	2022	"10.1186/s13054-022-04003-2"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial"	"No reply"
"BOX fever 2022"	"https://clinicaltrials.gov/ct2/show/NCT03141099"	"Management"	"Not drug trial"	2	"(1,5]"	802	"(500,1000]"	"No"	"3/2017-12/2021"	"2017-03-01"	"2021-12-01"	4.7534246575342465	"NEJM"	2022	"10.1056/NEJMoa2212528"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Duration of Device-Based Fever Prevention after Cardiac Arrest"	"Not used"
"LOVIT 2022"	"https://clinicaltrials.gov/ct2/show/NCT03680274"	"Drug"	"3"	35	"(20,40]"	872	"(500,1000]"	"No"	"11/2018-7/2021"	"2018-11-01"	"2021-07-01"	2.663013698630137	"NEJM"	2022	"10.1056/NEJMoa2200644"	"No"	"No"	"N/A"	"Not stopped"	"Not stopped"	"Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit"	"No reply"
"CLASSIC 2022"	"https://clinicaltrials.gov/ct2/show/NCT03668236"	"Drug"	"4"	31	"(20,40]"	1554	"(1000,2000]"	"No"	"11/2018-11/2021"	"2018-11-01"	"2021-11-01"	3	"NEJM"	2022	"10.1056/NEJMoa2202707"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Restriction of Intravenous Fluid in ICU Patients with Septic Shock"	"Not used"
"EXTUB-OBESE 2023"	"https://clinicaltrials.gov/ct2/show/NCT04014920"	"Device"	"Not drug trial"	39	"(20,40]"	981	"(500,1000]"	"No"	"10/2019-7/2021"	"2019-10-01"	"2021-07-01"	1.7479452054794522	"Lancet Respir Med"	2023	"10.1016/S2213-2600(22)00529-X"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of non-invasive ventilation after extubation in critically ill patients with obesity in France: a multicentre, unblinded, pragmatic randomised clinical trial"	"No reply"
"Heming 2022"	"https://clinicaltrials.gov/ct2/show/NCT02968836"	"Drug"	"2"	1	"(0,1]"	35	"(0,100]"	"No"	"6/2017-12/2019"	"2017-06-01"	"2019-12-01"	2.5	"Crit Care"	2022	"10.1186/s13054-022-04232-5"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of an enteral amino acid blend on muscle and gut functionality in critically ill patients: a proof-of-concept randomized controlled trial"	"No reply"
"HOST 2022"	"https://clinicaltrials.gov/ct2/show/NCT03929328"	"Device"	"Not drug trial"	1	"(0,1]"	108	"(100,250]"	"No"	"6/2019-1/2022"	"2019-06-01"	"2022-01-01"	2.5863013698630137	"Crit Care"	2022	"10.1186/s13054-022-04281-w"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of high-flow oxygen versus T-piece ventilation strategies during spontaneous breathing trials on weaning failure among patients receiving mechanical ventilation: a randomized controlled trial"	"No reply"
"HELMET-COVID 2022"	"https://clinicaltrials.gov/ct2/show/NCT04477668"	"Device"	"Not drug trial"	8	"(5,10]"	322	"(250,500]"	"Yes"	"2/2021-11/2021"	"2021-02-01"	"2021-11-01"	0.7479452054794521	"JAMA"	2022	"10.1001/jama.2022.15599"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of Helmet Noninvasive Ventilation vs Usual Respiratory Support on Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19 The HELMET-COVID Randomized Clinical Trial"	"Not used"
"PANAMO 2022"	"https://clinicaltrials.gov/ct2/show/NCT04333420"	"Drug"	"3"	46	"(40,100]"	369	"(250,500]"	"Yes"	"10/2020-10/2021"	"2020-10-01"	"2021-10-01"	1	"Lancet Respir Med"	2022	"10.1016/S2213-2600(22)00297-1"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial"	"No reply"
"DOLPHIN 2022"	"None"	"Management"	"Not drug trial"	8	"(5,10]"	450	"(250,500]"	"No"	"10/2018-9/2021"	"2018-10-01"	"2021-09-01"	2.9178082191780823	"Intensive Care Med"	2022	"10.1007/s00134-022-06921-9"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Model-informed precision dosing of beta-lactam antibiotics and ciprofoxacin in critically ill patients: a multicentre randomised clinical trial"	"Not used"
"ESCAPe 2022"	"https://clinicaltrials.gov/ct2/show/NCT01283009"	"Drug"	"3"	42	"(40,100]"	584	"(500,1000]"	"No"	"1/2012-4/2016"	"2012-01-01"	"2016-04-01"	4.248633879781421	"Intensive Care Med"	2022	"10.1007/s00134-022-06684-3"	NA	"Yes"	"No"	"Slow enrolment"	"Slow enrolment"	"Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia"	"No reply"
"PILOT 2022"	"https://clinicaltrials.gov/ct2/show/NCT03537937"	"Management"	"Not drug trial"	1	"(0,1]"	2987	"(2000,5000]"	"No"	"7/2018-8/2021"	"2018-07-01"	"2021-08-01"	3.084931506849315	"NEJM"	2022	"10.1056/NEJMoa2208415"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Oxygen-Saturation Targets for Critically Ill Adults Receiving Mechanical Ventilation"	"Not used"
"Bougle 2022"	"None"	"Management"	"Not drug trial"	30	"(20,40]"	190	"(100,250]"	"No"	"6/2016-5/2018"	"2016-06-01"	"2018-05-01"	1.915068493150685	"Intensive Care Med"	2022	"10.1007/s00134-022-06690-5"	NA	"Yes"	"No"	"Slow enrolment"	"Slow enrolment"	"Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial"	"No reply"
"CATCH 2023"	"https://clinicaltrials.gov/ct2/show/NCT03523039"	"Device"	"Not drug trial"	1	"(0,1]"	21	"(0,100]"	"No"	"2/2019-8/2021"	"2019-02-01"	"2021-08-01"	2.495890410958904	"Crit Care"	2023	"10.1186/s13054-023-04323-x"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Cytokine hemoadsorption with CytoSorb® in post-cardiac arrest syndrome, a pilot randomized controlled trial"	"No reply"
"Poole 2022"	"ANZCTR/ACTRN12616001135404"	"Management"	"Not drug trial"	16	"(10,20]"	434	"(250,500]"	"No"	"5/2017-11/2020"	"2017-05-01"	"2020-11-01"	3.504109589041096	"Am J Respir Crit Care Med"	2022	"10.1164/rccm.202202-0329OC"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"The Effect of a Liberal Approach to Glucose Control in Critically Ill Patients with Type 2 Diabetes: A Multicenter, Parallel-Group, Open-Label Randomized Clinical Trial"	"Not used"
"SOHO-COVID 2022"	"https://clinicaltrials.gov/ct2/show/NCT04468126"	"Device"	"Not drug trial"	34	"(20,40]"	782	"(500,1000]"	"Yes"	"1/2021-12/2021"	"2021-01-01"	"2021-12-01"	0.915068493150685	"JAMA"	2022	"10.1001/jama.2022.15613"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19 The SOHO-COVID Randomized Clinical Trial"	"No reply"
"HINFOR 2022"	"https://clinicaltrials.gov/ct2/show/NCT04125342"	"Management"	"Not drug trial"	2	"(1,5]"	182	"(100,250]"	"No"	"6/2020-6/2021"	"2020-06-01"	"2021-06-01"	1	"Intensive Care Med"	2022	"10.1007/s00134-022-06919-3"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Effect of postextubation noninvasive ventilation with active humidification vs high-flow nasal cannula on reintubation in patients at very high risk for extubation failure: a randomized trial"	"No reply"
"Lonze 2022"	"https://clinicaltrials.gov/ct2/show/NCT04343989"	"Drug"	"2+3"	5	"(1,5]"	178	"(100,250]"	"Yes"	"4/2020-12/2020"	"2020-04-01"	"2020-12-01"	0.6684931506849315	"Crit Care Med"	2022	"10.1097/CCM.0000000000005591"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation"	"No reply"
"AMBROISIE 2023"	"https://clinicaltrials.gov/ct2/show/NCT03335345"	"Management"	"Not drug trial"	22	"(20,40]"	1130	"(1000,2000]"	"No"	"4/2018-10/2019"	"2018-04-01"	"2019-10-01"	1.5	"Lancet Respir Med"	2023	"10.1016/S2213-2600(22)00413-1"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Continued enteral nutrition until extubation compared with fasting before extubation in patients in the intensive care unit: an open-label, cluster-randomised, parallel-group, non-inferiority trial"	"No reply"
"RESPONSE 2022"	"https://clinicaltrials.gov/ct2/show/NCT02860572"	"Drug"	"4"	2	"(1,5]"	141	"(100,250]"	"No"	"1/2017-11/2020"	"2017-01-01"	"2020-11-01"	3.8333333333333335	"Crit Care"	2022	"10.1186/s13054-022-04283-8"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Non-interventional follow-up versus fluid bolus in RESPONSE to oliguria in hemodynamically stable critically ill patients: a randomized controlled pilot trial"	"No reply"
"Lyu 2022"	"https://clinicaltrials.gov/ct2/show/NCT03872011"	"Drug"	"3"	1	"(0,1]"	426	"(250,500]"	"No"	"2/2019-6/2021"	"2019-02-01"	"2021-06-01"	2.328767123287671	"Crit Care"	2022	"10.1186/s13054-022-04175-x"	NA	"No"	"N/A"	"Not stopped"	"Not stopped"	"Early administration of hydrocortisone, vitamin C, and thiamine in adult patients with septic shock: a randomized controlled clinical trial"	"No reply"
